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Abstract 
This thesis aimed to determine the psychometric properties and applications of sensory threshold 
tools and outcome measures in patients with Carpal Tunnel Syndrome (CTS).  The first chapter 
is a psychometric study that defines clinically important difference (CID), construct validity and 
responsiveness of touch and vibration threshold tools and in the Symptoms Severity Scale (SSS). 
The study found the CID for the Pressure Specified Sensory Device (PSSD) and for the SSS was 
0.15g/mm
2
 and 0.50 respectively.  The study also found that the Vibrometer was more 
representative of hand function and responsive compared PSSD. The second objective of this 
thesis was to determine the feasibility of recruiting patients with CTS to test the effects of cell 
phone texting on sensory and functional outcome measures. The recruitment rate was 73% and 
touch threshold was most influenced by texting for patients.  Further research is required on the 
process of clinical decision making based on sensory tool evaluations.   
Keywords 
Carpal Tunnel Syndrome, sensation, Clinical Important Difference (CID), construct validity, 
responsiveness, feasibility, cell phone. 
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Chapter 1  
1 Background 
Carpal Tunnel Syndrome (CTS) is one of the most common neuropathies to the upper 
extremity.  In general, the presenting symptoms associated to CTS are the result of the 
compression of the median nerve beneath the transverse retinaculum.  
1
 Common signs 
and symptoms in diagnosed CTS are:  numbness, tingling, and pain in the hand, and 
nocturnal symptoms. 
2
  The cause of CTS is controversial, as it can be caused by a 
multitude of physiological changes to the nerve, surrounding structures within the carpal 
tunnel structure, or vascular changes.  Some reasons for the cause of CTS include:  
edema causing increase pressure within the carpal tunnel, 
1
 fibrosis, 
1
 or the entrapment 
of blood resulting in ischemia by surrounding tissue.  
3
  Chronic compression of the nerve 
has been thought to result in decreased blood flow to large fibers and result in 
demyelination. 
4
 One of the common symptoms to CTS are sensory changes, and in the 
ability for patients to perceive specific stimuli, particularly touch and vibration threshold.   
Vibration threshold changes occur early in neuropathy, while pressure thresholds tend to 
change in later stages of CTS. 
5
 Sensory recovery is an important part of the rehabilitation 
process for patients with CTS.  During the evaluative process of patients with CTS, it is 
important that sensory tools provide useful information to inform clinicians on the status 
of the patients’ sensory recovery and to make decisions 6on whether to proceed with 
different treatment or to end treatment.  Tools should be validated for construct validity, 
6
 
be responsive to treatment, 
6
 and have a defined clinically important difference.   
Furthermore, beyond clinical use, the application of sensory tools could be used in testing 
novel day to day activities which patients may come across.  It is possible that specific 
activities may alter sensation and aggravate symptoms patients currently experience.  
With these concepts in mind, this thesis is intended to explore the psychometric 
properties and specific applications of sensory tools and outcome measures.  We will 
briefly summarize the epidemiology, clinical background on sensory changes, properties 
2 
            
       
of the Pressure Specified Sensory Device (PSSD) and Vibrometer, summary of 
limitations in current literature, and an overview of the objectives for this thesis.     
1.1 Epidemiology 
Within the province of Ontario in Canada, CTS occurred at rate of 29 out of 100,000 
workers in 1997. 
7
 More than half of the persons affected are women (54%) and generally 
occur between 35- 54 years of age. 
7, 8
 In 1997, the injury was highest among the textile, 
fur and leathers, machine operation, and transportation. 
7
 In the United States of America, 
occupational surveys from data in 2010 reported that the lifetime prevalence of clinician 
diagnosed CTS was 6.7% of the population. 
9
   
The risk factors or potential causes of CTS within workplaces have been studied 
extensively.  Potential reasons for the cause of CTS are:  nature of the job demands, 
gender differences, elevated body mass index, 
10
 medical history (previous fracture or 
mechanical neck problem), 
10
 individual characteristics (caffeine consumption and 
diabetes). 
11, 12
 For professions requiring highly repetitive movement involving awkward 
postures of the upper extremity, mechanical pressure on finger tips, and twisting of the 
wrist have been documented to have a higher risk of workers developing CTS than jobs 
not requiring such tasks
13
.  Other reasons that may cause CTS are pregnancy 
14-19
 and 
recent injury to the upper extremity. 
20
 Recent injury to the upper extremity may cause 
carpal tunnel syndrome because of potential impingement of the median nerve in cases 
with distal radius fractures. 
20
 There is controversy about the extent to which CTS is 
work-related or a result of genetic factors, and how these are reflected in health 
conditions with co-morbidities.  
3 
            
       
1.2 Clinical Presentation of CTS 
 
When nerve injury occurs, there is first intermittent paraesthesia that is experienced. 
21
  
As neuropathy progresses, patients experience constant paraesthesia, and weakness in the 
hand. 
21
 In late stages, there is numbness and potential paralysis in the hand. 
21
 Sensation 
is altered and an increase in touch and vibration threshold occurs during early stages of 
nerve injury. 
4
 There are five classes of nerve injury, where the severity is rated from 1 to 
5.  Carpal tunnel syndrome is a compression neuropathy that crosses categories 1 to 3 
because categories 4 and 5 involve transection of the nerve (Table 1). 
4, 5, 22
 Each category 
of CTS presents itself with different presentation of alterations to sensation from 
physiological changes to the median nerve and associated structures (motor and sensory) 
to the median nerve. 
Table 1.1:  Categories of Nerve Injury Classification 
 Neuropraxia Axonotmesis 
Sunderland 
Categories of 
Nerve Injury 
Classification 
and 
Presentation  
Category 1 (early 
stage of CTS):  
Conduction block, 
Axon remained 
normal.  Initial 
sensation of 
parathesia. 
Focal 
demyelination 
Category 2 – axon loss.  
Intact endoneurium.  
Wallerian degeneration 
of distal nerver and 
myelin sheath. 
 
Category 3 (late stage 
CTS) – loss of 
continuity of axons and 
endoneurium.  
Perineurium intact.  
Wallerian degeneration 
At distal end.  
Endoneural scarring.  
Chance of recovery 
dependent on content in 
fascicles. 
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 Mild Moderate Severe 
Symptomology 
4, 22, 23
 
Mild symptoms of 
tingling, pain, and 
numbness 
Mainly nocturnal 
symptoms 
Day symptoms – 
wrist in flexed 
position at 1min 
No abnormal 
findings  
+/- Tinel and 
Phalen’s 
Persistent symptoms 
Decreased tactile 
sensation  
Loss of dexterity  
Weak grip and pinch 
Symptoms increase at 
night 
Burning pain, swelling 
or tightness in hand  
Varied degree of thenar 
weakness/atrophy 
Skin changes 
Decreased protective 
sensation 
Greater 2PD values  
Definite +ve Tinel’s 
and Phalen’s 
Decreased nerve 
conduction on EMG 
Prolonged neuropraxia 
Marked by decreased 
2PD 
Decreased tactile 
gnosis 
Impaired dexterity and 
function 
Weakness of 2 
lumbricals and thenar 
muscles. 
Atrophic skin changes 
+/- Tinel’s and 
Phalen’s 
Severely decreased 
nerve conduction on 
EMG 
PD = point discrimination.  EMG = Electromyography 
5 
            
       
Categories 4 and 5 of Sunderland Categories of Nerve Injury Classification do not 
represent CTS because they involve complete transaction of the nerve.  Nerve transection 
is not a characteristic of CTS.   
1.3 Treatment 
 
The initial treatment process of non severe cases of CTS usually involves non surgical 
treatment, often involving orthotic intervention (splinting). 
24
 If orthotic intervention 
fails, surgery is the next level of treatment. 
25
 The decision to proceed to surgery is based 
on patient’s concerns, and/or based on the clinician’s decision from a number of clinical 
outcome measures.  The clinician’s decision to send a patient on towards surgery or to 
end treatment is based on whether the changes in outcome measures from follow up 
appointment presented a clinically important difference.  Ozyurekoglu et al 
26
calculated 
the minimal clinically important difference (MCID) for the Symptom Severity Scale 
(SSS) in a group of patients with CTS after conservative treatment with steroid injection.  
They found that the MCID was 1.04 on the SSS. 
26
 However, we are unaware from 
previous literature on the clinically important difference for orthotic intervention.  
Likewise, clinicians use a battery of sensory tests, such as touch threshold and vibration 
threshold, to evaluate sensory threshold.  We are uncertain of previous literature which 
has documented the clinically important difference of the SSS and sensory threshold tools 
after orthotic intervention.  A study is needed to address this gap in literature.   
1.4 Clinical Outcome Measures and Properties  
Pressure specified sensory device (PSSD). The Pressure Specified Sensory 
Device (PSSD) is a sensory threshold tool used commonly within research 
settings. The PSSD can measure static one point (1PS), static two point (2PS), 
moving one point discrimination (1PM), and moving two point discrimination 
(2PM).  The purpose of these tests are to measure cutaneous pressure threshold on 
the surface of skin to detect pressure (1 point testing) and to discriminate one 
prong from two prongs (2 point testing), targeting sensory receptors for measuring 
6 
            
       
both static and dynamic stimuli. 
27
 The PSSD has demonstrated construct validity 
in relation to the nerve conduction studies, 
28, 29
 with object identification with 
2PD, 
30
 and valid to be used for groups with neuropathy caused by diabetes. 
31
 
The PSSD has shown to be a reliable tool, 
27
 and shows expected physiological 
relationships between pressure threshold and the distance between stimuli. 
32
 
Although there are many sensory tools, the PSSD cannot be compared to other 
measurement tools for sensation, such as Semmes Weinstein monofilament 
(SWMF) because poor correlations have been shown between the two tools (r = 
0.21 - .29). 
33
 Thus, previous psychometric properties determined for the SWMF 
should not be used as evidence to support the PSSD, although they both measure 
the construct of touch threshold, 1 point and 2 point testing for both static and 
dynamic.  The PSSD has been extensively studied using 2 point discrimination, 
30
 
but 1 point static testing has not been validated for construct validity in relation to 
symptom severity, self reported hand function, and dexterity for patients with 
CTS.  The PSSD values have been shown to significantly change after carpal 
tunnel release, 
34
 but a study on responsiveness of the PSSD has not been 
examined.  Quantifying the responsiveness would allow the responsiveness of the 
PSSD to be compared to other sensory measures.  An examination of the 
psychometric properties would be required to justify the utility of touch threshold 
testing with 1 point of the PSSD in patients with CTS.    
The Vibrometer.  The Vibrometer measures vibration threshold or the minimum 
amount of stimulus that is required to elicit a response (with the vibration 
amplitude usually measured in micrometers (um).   The Vibrometer is commonly 
used for diagnostic purposes to detect for impairments to the peripheral nerve 
35, 36
 
because the fibers responsible for detecting vibration threshold are affected early 
during neuropathy. 
4
 The Vibrometer has been found to have low construct 
validity with nerve conduction studies, 
35, 37-40
 but mixed findings on whether it is 
more sensitive to detect neuropathy compared to standard nerve conduction 
testing. 
37
  The Vibrometer has demonstrated moderate correlation with dexterity 
testing (r = -0.62). 
30
 The tool has also been found to be reliable. 
41, 42
 However, 
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the construct validity of the tool has not been assessed in relation to self reported 
measures of function and symptom severity.  There is a disproportional amount of 
research focus on relating performance based tools (i.e. electromyography) to 
represent function, rather than determining the association of vibration threshold 
to the symptoms (for example, pain or numbness) that patients experience.   An 
examination of self reported symptoms in relation to vibration threshold would 
allow clinicians to make more informed decisions by understanding how vibration 
threshold is associated to patients’ hand function. In addition, there is no clear cut 
point to indicate a clinically important difference for the Vibrometer for 
evaluating patients with CTS who undergo orthotic intervention to determine 
whether they should continue to proceed with surgery or to end treatment.   
Symptom severity scale (SSS). The Symptom Severity Scale (SSS) is a 
questionnaire with 11 questions 
43, 44
 specifically designed to assess the symptom 
severity experienced by patients with CTS. 
43
 The tool has demonstrated construct 
validity, 
43
 and reliability. 
43, 45
 The SSS has also been shown to be responsive 
after treatment for surgery, 
44, 46-48
 and after steroid injection. 
26
  The minimal 
clinically important difference has been demonstrated for surgery, 
48
 and after 
steroid injection. 
26
  However, the cut point for clinically important difference is 
for the SSS after orthotic intervention has not been established.  The clinically 
important difference may help clinicians discriminate whether patients should 
proceed to surgery or not after orthotic intervention.  When testing for clinical 
properties of sensory tools, in theory, the SSS should demonstrate a correlation 
with overall hand function and dexterity.  However, previous research has not 
shown the association between the SSS to other measures of hand function.  It is 
not clear how symptoms are correlated to hand function.  A psychometric study 
should be performed to establish the cut point for the clinically important 
difference and the construct validity of the SSS in relation to self reported 
measures of hand function.  
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1.5 Changes to Blood Flow 
In a patient affected with CTS, there is a breakdown of the blood nerve barrier of the 
median nerve from elevated pressure, resulting in inflammation within the tissue. 
49
  
Previous research has found that patients have impaired control of blood flow. 
50-55
 
Previous in-lab and clinical testing has found that the sympathetic response is slower and 
recovery is delayed before and after exercise in patients with CTS. 
50-55
 Patients with CTS 
have also been shown to have slower blood flow velocities compared to people without 
CTS. 
50, 52, 53
 One study indicated that blood flow was faster in patients with CTS 
compared to healthy participants. 
52
 These previous studies 
50, 52, 53
 have utilized Doppler 
system and thermography to measure vascular performance in patients with CTS.  
However, one of the limitations of these tools is that they cannot measure red blood cell 
concentration specifically at one instantaneous point time, and can only measure blood 
flow.  Focusing on an instantaneous red blood cell concentration would be advantageous 
to describe the influence of CTS on blood circulation in areas where sensation is altered.  
In addition, we can see how specific activities with the hand would influence blood flow.  
This information would be useful for understanding how blood circulation is affected by 
CTS.   
1.6 Applications of Sensory Tools in Hand Activity:  Cell Phone Use  
Cell phone texting is an increasingly popular method of communication,
56
 and research 
describing the physiological changes from texting is fairly novel among different 
populations.  Most research on describing physiological changes from cell phone texting 
57-59
has primarily focused on university student populations with and without 
musculoskeletal symptoms.  Gustafsson et al 
57
 found that subjects with musculoskeletal 
symptoms had lower muscle activity in the thumbs but higher activity in the trapezius 
compared to those participants without symptoms. 
57
 In a preliminary study, Lin and 
Peper 
58
 found that texting increases respiratory rate, heart rate, and self reported stress 
levels. 
58
 Research studies have also suggested that cell phone texting may result in pain 
experienced on the upper extremity. 
59
 To our knowledge, no research has examined the 
9 
            
       
effect of cell phone texting on a patient population with clinically diagnosed CTS.  
Postures, motions, and forces obtained during cell phone texting by patients with CTS 
may result in an increase in sensory thresholds, altered blood flow, and aggravated 
symptoms.  Understanding the sensory, vascular, and symptomatic changes that may 
occur with texting might allow clinicians or ergonomists to understand the impact of 
texting on clinical outcome measures in a patient population with CTS.  The first stage of 
research should be to determine the immediate impact of texting in patients and in age 
matched controls to determine if there are immediate changes in physiological function in 
responses to clinical tools. The findings from this pilot study would inform the feasibility 
of completing a larger future study on the long-term effects of texting.  A feasibility study 
should be performed to determine the influence of texting on clinical outcome measures 
in patients with CTS on this novel topic.    
1.7 Summary of Limitations in Current Knowledge 
Sensory evaluation is an important part of the treatment process to evaluate the severity 
of CTS that patients have.  It is important that tools can discriminate patients with CTS 
who have undergone treatment and to determine the next step in the treatment process, 
specifically whether patients with CTS going through orthotic intervention should 
continue towards surgery or not.  It would be equally important to know the 
responsiveness of sensory tools and construct validity of sensory tools to determine 
which sensory tools are more representative of hand function.  However, we could not 
locate these psychometric properties in previous literature on the PSSD and the 
Vibrometer.  In addition, the application of sensory tools to measure sensory and 
functional changes in patients with CTS under conditions after newly emerging hand 
activity, such as texting on a cell phone.  These findings would provide insight into how 
patient populations are affected by texting activity and their performance are impacted by 
CTS.  
10 
            
       
1.8 Purpose of this Thesis   
The central question of this thesis was to determine the physiological response to 
(potentially risky) exposures and intervention in patients with CTS and its potential 
impact on sensory improvement.   
This thesis attempted to identify the following objectives in patients with CTS: 
 The psychometric properties of two sensory threshold devices (the Pressure 
Specified Sensory Device (PSSD) and Vibrometer), and the Symptom Severity 
Scale (SSS), in terms of the clinically important difference, construct validity to 
functional outcome measures, and responsiveness after orthotic intervention 
 The potential differences in sensory measures and outcome measures between 
patients and healthy individuals after texting on a cell phone through a pilot study  
 
1.9 Thesis Overview 
This thesis is composed of 2 manuscripts.  The first manuscript is located in Chapter 2 
and the second manuscript is located in Chapter 3.   
The aim of the manuscript in Chapter 2 was to determine a number of the psychometric 
properties of the Pressure Specified Sensory Device (PSSD), the Vibrometer and the 
Symptom Severity Scale (SSS).  Specifically, the primary objective of this study was to 
determine the CID of the sensory tools and in the SSS to discriminate patients who were 
successfully treated with orthotic intervention and patients who needed to proceed further 
with surgery.  The secondary objective of this study was to determine the construct 
validity and responsiveness of sensory threshold tools and in the SSS.  This study was 
able to identify differences in properties between the PSSD and the Vibrometer, suggest 
rational for these properties, and which tool would be more useful in discriminating 
patients with CTS after orthotic intervention and representative of overall hand function.      
11 
            
       
Chapter 3 was dedicated to determining the feasibility of recruiting patients with CTS, 
and to describe the effects of cell phone texting on their touch threshold, superficial blood 
flow, and self reported symptom ratings.  The objective of the study was to determine 
differences between a group of patients with CTS to an age-and-gender matched control 
group.  We determined that a full study to determine the effects of cell phone texting was 
feasible to perform over the recruitment period and a full study could be completed in the 
future.  We were able to identify factors which reduced the number of eligible patients in 
the study.  We also found that patients experienced more symptoms throughout the study 
compared to age and gender matched controls and symptoms worsened from texting.  
Patients experienced a significant increased in touch threshold and fatigue compared to 
baseline levels after texting.  Since studies the physiological effects of cell phone texting 
are limited, this study serves as an early effort to describe potential adverse effects of cell 
phone texting in a patient population with CTS and in healthy age and gender matched 
controls.   
In summary, this thesis is intended to bridge specific gaps in literature behind the 
measurement properties of sensory tools for evaluating patients with CTS in clinical and 
non clinical environments. 
12 
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Chapter 2  
2 The Construct Validity, Clinically Important Differences, and 
Responsiveness of Symptom Severity Scores, and Sensory Tests in Patients 
with Carpal Tunnel Syndrome 
 
A version of this chapter has been submitted for publication 
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2.1 Introduction 
Carpal Tunnel Syndrome (CTS) is a common compression neuropathy with an annual 
prevalence ranging between 2.7% in Sweden 
1
 to 6.7% in the United States of America. 
2
  
Incidences of Carpal Tunnel Syndrome can vary depending on the type of the occupation.  
In 1988 and 2010, industry related jobs (for example, manufacturing and food services), 
contributed to the majority of work related CTS cases in the United States of America 
based on National Health Surveys. 
2, 3
 For workers employed within educational 
institutions, a lower prevalence of CTS injury was found. 
2
 CTS is a major contributor to 
occupational upper extremity disorders, 
4, 5
 and is associated with considerable health 
care costs. 
6
 
Typical sensory symptoms experienced by patients with CTS are tingling, pain, and 
numbness at night or throughout the day; with advanced stages of the disease affecting 
motor function and dexterity. 
7-12, 12-14
 A number of clinical tests are performed to 
evaluate hand function in patients with CTS, 
15-20
 such as sensory tests, 
21
 or disease 
specific questionnaires. 
22
 These clinical tests can help clinicians determine if a patient 
responded to treatment; and if carpal tunnel release is required. 
15
 The Clinically 
Important Difference (CID) is a measurement property for responsiveness that indicates 
the change scores on an outcome measure that is considered to provide important 
information for a clinician or patient for deciding the next step in a treatment protocol.  
This CID could be used to discriminate patients who make clinically important changes; 
indicating a clinical improvement following treatment.  Studies that identify CID must 
divide patient responses as clinically important versus clinically unimportant to determine 
the optimal cut-off.  Thus, an external criterion on another outcome measure must be 
used to make this judgment.  A variety of methods can be used as an external criterion to 
determine whether a patient has made a clinically important change.  As for patients with 
CTS, if symptoms resolve with conservative treatment, this could be considered an 
external criterion for demonstrating clinical improvement.  If symptoms continue despite 
22 
            
       
conservative treatment, the patient did not experience a clinical important change, and 
surgery would be the next treatment option.  The Symptom Severity Scale (SSS) is a 
commonly used self-reported questionnaire designed specifically for evaluating 
symptoms in CTS. 
22
 The CID of the SSS is equal to 1.04 or 1.14, depending whether the 
treatment method is by steroid injection 
23, 24
 or with carpal tunnel release 
25
 respectively.  
However, the CID for orthotic intervention has not been identified in literature or 
identified for clinical practice.   
In addition, sensation is an important component of hand function, 
19, 26
 and is typically 
impaired in CTS.  Sensory testing is important to assist clinicians in the diagnosis of 
CTS; to determine severity; or to monitor improvements with treatment.  A variety of 
tools can provide quantitative measures of sensory threshold for different modalities, 
including touch and vibration threshold. 
15-17, 19
  Two sensory tools which are often used 
in clinical studies to measure sensory characteristics are the Pressure Specified Sensory 
Device (PSSD) (NK Biotechnical Corporation, Minneapolis, MN, USA) and the 
Vibrometer (Z tech Medical, Salt Lake City, UT, USA).  Some clinical measurement 
properties of the PSSD and Vibrometer have been reported.  The PSSD has been shown 
to have high reliability (r= 0.95) and interrater reliability in healthy persons for one point 
static testing (r= 0.99). 
27
 The Vibrometer has excellent test-retest reliability in patients 
with CTS with intraclass correlation coefficients (ICCs) ranging from 0.86 to 0.89. 
28
 
However, there is limited evidence about the discriminative and evaluative properties of 
sensory measures - in particular to touch and vibration threshold tools.  There is a specific 
deficit of knowledge about the CID of sensory tools, which is a substantial gap in clinical 
knowledge since this is the measure that would be relevant for clinical decision making 
regarding whether patients have made clinically relevant improvements.    
The purpose of this study was to evaluate the clinical measurement properties of the 
Vibrometer and the PSSD and self-reported measures of symptoms severity in patients 
with CTS, in terms of the following: 
1. The convergent construct validity in relation to measures of self-reported and 
performance-based hand function (DASH and NK Dexterity).  
23 
            
       
2. The CID of the SSS (established by comparison to the external criterion of failure to 
achieve symptom relief as indicated by progression to surgery). 
3. The CID of the Vibrometer and PSSD.  
4. The responsiveness of the Vibrometer and PSSD in patients who achieved a 
clinically important improvement in symptoms.  
 
2.2 Methods  
All patients were recruited from a tertiary care center specializing in upper limb 
disorders.  Patients were diagnosed with CTS based on a clinical diagnosis made by the 
treating hand surgeons and confirmed by electromyography (EMG) based on the latest 
version of the American Association of Electrodiagnostic Medicine criteria as outlined by 
consensus criteria by Rempel et al. 
14
 Patients were included in the study if they had mild 
CTS, as conservative management is appropriate for this particular category of the 
disease. 
29
 Patients were excluded from the study if they met any of the following criteria:  
Exclusion Criteria: 
 Urgent or severe CTS requiring early operative intervention; 
 Pregnancy 30-32; 
 Concurrent injury to the upper extremity including recent trauma (i.e. fracture, 
amputation, tumor, or nerve compression); 
 Wrist arthritis, rheumatoid arthritis, diabetes mellitus, or thyroid disease;  
 Inability to complete study forms/assessments; and  
 Neurological conditions 
24 
            
       
This study was approved by the university research ethics board and informed consent 
was obtained from each patient.   
Sample size justification. The sample size was determined for the correlation between 
sensory tools and SSS, DASH, and Dexterity to achieve significance using G*Power 
version 3.1.4 software  
(http://www.psycho.uni-duesseldorf.de/abteilungen/aap/gpower3/download-and-register) 
at a power of 80% with a correlation of 0.5 with a bivariate normal model.  Alpha was set 
at 0.05 using a 2 tail test.  The minimum sample size required was 29 patients.  Statistical 
significance was considered if p<0.05.    
2.3 Outcome measures.   
Pressure specified sensory device (PSSD).  The PSSD is a computerized touch 
threshold device, which can measure the minimum amount of pressure required to 
elicit a response from a subject (g/mm
2
), as well as spatial discrimination (2 Point 
Discrimination) (2PD).  It has a range of 0.1 to 100 g/mm
2
.  Each hemispheric 
prong has an area of 0.90mm
2
.  This study tested touch threshold only with the 
PSSD.  For touch threshold of a single point, the tester applied an individual 
metallic prong from the PSSD device into the distal pulp of the long finger in the 
affected hand while the participant sat with eyes closed.  Participants were 
instructed to push a trigger held in the opposite hand, to identify when they 
perceived the stimulus.  The PSSD has been shown to have high reliability (r= 
0.95) and intertest reliability in patients with neuropathy for one point static 
testing (r= 0.99). 
27
 For each visit, a total of five repetitions were taken; the lowest 
and highest scores were dropped and the remaining three were averaged as 
recommended by the manufacturer.  A total of three visits were required.   
The vibrometer. The Vibrometer is a sensory modality which measures vibration 
perception threshold. 
33
 The Vibrometer used in this study is a 50 Hz computer-
controlled ramped protocol where the vibration stimuli are applied through a 2mm 
diameter aperture with a 1mm diameter vibrating post.  Subjects were required to 
25 
            
       
identify when they felt a stimulus by squeezing a handheld trigger with their eyes 
closed.  The minimum score is 1 um and the maximum score is 180um.  A 
ramped protocol is regulated by the device supplying sufficient repetitions of test 
stimuli; to achieve a stable estimate of vibration threshold.  The Vibrometer has 
shown excellent test retest reliability in patients with CTS with ICCs ranging from 
0.86 to 0.89. 
28
 The Vibrometer was tested once at each follow up point and for a 
total of 3 times. 
The symptom severity scale (SSS).  The SSS is a disease specific questionnaire 
composed of 11 questions each rated 1 through 5 that measures symptoms 
experienced in a typical 24 hour period within the past 2 weeks.  Respondents rate 
the severity of CTS-related symptoms and disability with scores ranging from 1 
(no symptoms) to 5 (worst). 
22
 The final score for the SSS is calculated as a mean 
of 11 questions.  It has been assessed and found to be valid for face, content, and 
construct validity in measuring clinically relevant change in patients with Carpal 
Tunnel Syndrome. 
22, 34-36
 It has also been shown to be reliable for test-retest 
reliability. 
22, 37
 The questionnaire was completed once per visit and patients were 
required to complete the questionnaire a total of 3 times.   
Disability of the arm, shoulder, and hand (DASH) questionnaire.  The DASH 
is a self–report measure which allows patients to rate the disability of their arm, 
shoulder and hand. 
38
 Responses range from 1 to 5, with a higher score indicating 
higher levels of pain and disability.  The questionnaire has been shown to be 
responsive after Carpal Tunnel Release surgery. 
39
 The convergent, construct, and 
discriminatory validity has been supported for distal upper extremities, including 
Carpal Tunnel Syndrome. 
40
 DASH has also been found to be responsiveness to 
clinical change. 
40
 The questionnaire was completed once per visit and patients 
were required to complete the questionnaire a total of 3 times.  
NK dexterity small objects test.  The NK Dexterity Small Objects Test (referred 
to as “Dexterity” for short) is a test of manual dexterity which measures the 
amount of time (in seconds) that is required for a patient to move objects on a 
26 
            
       
plastic board. 
41, 42
 Sizes of the objects are classified as small, medium, or large.  
It consists of plastic and metal objects that need to be moved with the affected 
hand and placed into another location.  Timing was initiated from the moment the 
hand moved from the starting position towards the first object until subjects 
removed their hand from the final object.  For this study, dexterity testing was 
done with the small objects only because fine motor function is expected to be 
most affected in CTS. 
41
 In addition, the small object subtest has been shown to 
have the best correlation to hand function with r = 0.47-0.87; and also has high 
reliability (ICC = 0.53-0.86). 
41, 42
 The time recorded for the patient to complete 
the dexterity task was the mean of 3 trials at each follow up point.   
2.4 Procedure 
Each patient was treated with night orthotic intervention of the wrist in neutral position 
for 12 weeks; and had assessments at baseline, 6 weeks, and 12 weeks later.  If patients 
and surgeons felt that orthotic intervention was not reducing symptoms, then surgery was 
offered.  Patients were monitored for a year following the intervention to determine 
whether they proceeded to surgery. 
At baseline and at each follow up visit, patients completed the following assessments:  
PSSD, Vibrometer, SSS, DASH, and Dexterity.  Data for the PSSD and Vibrometer were 
collected by having each patient seated with their affected arm supported on a table.  For 
the PSSD, the wrist was supported by a piece of foam, such that the wrist was in neutral 
position and the palm was facing upwards.  Data for the Vibrometer was collected by 
having the arm rest directly on the table with the hand in pronated position.  The long 
finger was used for testing sensation in both PSSD and Vibrometer testing.  Testing was 
done on the affected hand if CTS was affecting only one side; otherwise, the hand with 
more severe symptoms was tested for subjects who had CTS in both hands. 
2.5 Analysis 
All analyses were performed using SPSS software version 19. Data were checked for 
normality 
43, 44
 by checking the skewness ratio for each outcome measure were between ± 
27 
            
       
2. 
44, 45
 The Shapiro-Wilk test was also evaluated to determine if data were normal as a 
verification process.  If p>0.05, the data are normally distributed.  Otherwise, if p<0.05, 
the data are not normally distributed. 
44
 The data were not normally distributed (p<0.05), 
thus non-parametric statistics were used for correlations. 
Cross-sectional convergent validity. Cross Sectional Convergent Validity 
assesses the extent to which a measure’s result agrees with another measure that is 
believed to be assessing the same or similar attribute. 
46
 The correlation between 
the PSSD and the Vibrometer to measures of hand function were determined 
using Spearman’s correlation (rs) since the data were not normally distributed.  
Interpretation was based on the guidelines that Spearman’ correlation are 
considered poor if rs< 0.25, considered moderate if rs = 0.25 - 0.50, considered 
good if rs = 0.50 - 0.75 and considered excellent if rs > 0.75. 
43
   
Calculating clinically important difference (CID) for SSS. The CID was 
determined using Receiver Operating Characteristic (ROC) curves to determine 
the cutoff point to dichotomize and categorize the sample into 2 groups.  The first 
criterion to determine if an important change occurred was based on patients 
proceeding toward surgery.  The SSS was used to determine a cut-off score to 
discriminate clinically important change.  The patients were categorized either as 
responders (those who responded to orthotic intervention and did not proceed to 
surgery) or non-responders (those who did not respond to orthotic intervention 
and proceeded to surgery).     
The final follow-up visit was based on scores at 12 weeks.  For patients (n = 21 
for the PSSD and n = 22 for the Vibrometer) who did not return for their final 
follow-up, the score at 6 weeks was carried forward as it represented the last 
known status; and our previous studies have shown that patients who are going to 
respond to treatment will do so within the first six weeks. 
24
 ROC curves were 
used to establish the discriminative ability of the cut-off score; and to determine 
the optimized cut-off.  ROC curves plotted sensitivity (y-axis) versus 1 – 
specificity (x-axis).  For the ROC curves for the SSS, sensitivity is defined as the 
28 
            
       
number of patients who achieved a change score that was less than the cut off 
divided by all those who proceeded to surgery.  Specificity refers to the number of 
patients who achieved a change greater than the cut-off score divided by those did 
not proceed to surgery.  Whereas for the sensory tools, sensitivity is defined as the 
number of patients who did not achieve an important change divided by those 
who achieved a change score less than the cut off on the SSS.  Specificity refers 
to the number of patients who achieved an important change divided by those 
who had scored more than the cut off on the SSS.  The most efficient cut off score 
is the point closest to the top left corner of the ROC curve.  If the area under the 
curve (AUC) is equal or less than 0.50, this would mean the curve is no better 
than chance to discriminate patients.  Generally, an area under the curve > 0.75 is 
considered to be clinically useful. 
47
  
Calculating clinically important difference (CID) for the vibrometer and 
PSSD. Once the CID was calculated for the SSS, this cut score was used to 
determine the CID of the two sensory tools.  ROC curves were used to establish 
the discriminative ability of the cut score and the optimized cut off.  If the area 
under the curve (AUC) is equal or less than 0.50, this would mean has no better 
than chance ability to discriminate.   
Responsiveness. Responsiveness is the ability of a tool to measure a clinically 
important change that is noticeable to the patient or the clinician. 
48
 There are two 
broad methods of determining clinically meaningful change:  anchor and 
distribution-based approaches.  Both were used in this study. 
 Anchor based methods define clinically important change based on an external 
anchor, 
49
 which can be based on a subjective opinion (from a clinician’s or 
patient’s perception) or from an objective measures (such as a disease specific 
tool). 
49
 The anchor must be clearly defined and be able to show clinically 
important difference between groups at one instant (cross sectional approach) or 
over a period of time (longitudinal approach). 
50
 Often, a global rating of change 
is used to determine subjective change.  Although this method is easy to apply, it 
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is subject to recall bias.  The use of a disease specific tool is more accurate to 
measure important change because it is a standardized tool in clinical practice.  
This study used the SSS as the external anchor.   
Distribution based methods focus on statistical properties of a tool for measuring 
clinically important change. 
50
 There are three approaches of distribution based 
methods (statistical significance, sample variation, and measurement precision), 
but only sample variation will be explained for the case of this paper.  One of the 
more common methods of measuring sample variation are Effect Size (ES) and 
Standardized Response Mean (SRM).  These are the two distribution based 
methods used in this study.  The ES was calculated by dividing the mean change 
by the standard deviation of baseline scores. 
51
 The SRM was calculated by 
dividing the mean difference of the change scores by the standard deviation of 
change. 
52
    
The SRM and ES were calculated for both the responder group and the non-
responder groups for the SSS, the PSSD, and the Vibrometer based on the CID’s 
established in this study for the SSS.  The change scores were calculated in the 
same way when determining the CID for the SSS, PSSD, and Vibrometer.  
Responsiveness was defined as low if SRM and ES were < 0.5, moderate if SRM 
and ES were between 0.5 to 0.8 and large responsiveness if ≥ 0.8. 53, 5437 
2.6 Results 
A total of 73 patients (20 men and 53 women) were eligible for inclusion in this study.  
Patients were between the ages of 29 to 74 years (mean age of 49 ± 9 years).  The 
duration of the symptoms ranged from 1 month – 30 years (mean 4 ± 6 years) (See Table 
1).  Tables with baseline and follow up scores for PSSD, Vibrometer, DASH, SSS, and 
Dexterity are shown in Table 2.  Only 63 patients out of 73 patients completed the SSS.  
From this group of 63 patients, 38 patients completed the PSSD, and 22 completed 
testing with the Vibrometer for both baseline and final follow up.   The SSS, PSSD, and 
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the Vibrometer had 2, 1, and 5 patients respectively who had their scores at 6 weeks 
carried forward to 12 weeks. 
The Vibrometer demonstrated moderate correlations to symptoms and dexterity at most 
follow-up assessments; and was more strongly related to these tools than was the PSSD 
(Table 3).  The Vibrometer had low to moderate correlations with the SSS (r = 0.22 – 
0.41) and moderate correlations with Dexterity (r = 0.36 – 0.41) (Table 3).  The PSSD 
demonstrated low correlation to both SSS (r = 0.22 – 0.32) and Dexterity (r < 0.32) 
(Table 3).  Neither sensory measure correlated significantly to the DASH (r = 0.09 – 
0.30) (Table 3).  The SSS demonstrated moderate correlation to dexterity; and a large 
correlation to the DASH (0.63 – 0.76) (Table 3).   
 The CID for the change in the SSS that best differentiated response to orthotic 
intervention was 0.5 points (86% sensitivity; and 54% specificity); with an area under the 
curve of 0.73 (0.60, 0.86) (Figure 1 and Table 4).  The CID for the PSSD was equal 
0.15g/mm
2 
(60% sensitivity; and 39% specificity) with an area under the curve of 0.46 
(0.27, 0.64) (Figure 2).  The ROC curve for the Vibrometer could not be graphed because 
all 22 individuals improved at least 0.5 points on the SSS and the cut-off point did not 
provide any values for the x axis for 1-specificity (Table 5).   
The SSS demonstrated expected large responsiveness for responders (SRM= 2.18 (±0.42) 
and ES = 1.40 (±0.42)) and low responsiveness for non responders (SRM = 0.15(±0.31) 
and ES = 0.08 (±0.25)) (Table 5).  The PSSD demonstrated low responsiveness for both 
responder (SRM = 0.09 and ES = 0.08) and non responder (SRM = 0.04 and ES = 0.06) 
(Table 6).  The Vibrometer demonstrated moderate responsiveness for responders (SRM= 
0.61 and ES = 0.46) to treatment and low responsiveness for non responders (SRM = 
0.18 and ES = 0.12) (Table 6).   
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Table 2.1:  Demographic information of patients 
Total Number of Participants  73 
Number of Males  20 
Number of Females  53 
Mean Age and Range  49 ± 9 years (29 – 74 
years) 
Symptoms Duration   4 ± 6 years (1 month – 30 
years) 
Left Hand Affected:   10 
Right Hand Affected 25 
Both Hand Affected 38 
Heart Problems 7 
Diabetes 5 
Arthritis:   26 
WSIB Compensation cases:  18 with 4 pending 
 
WSIB = Workplace Safety Insurance Board  
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Table 2.2:  Baseline descriptive data 
 PSSD Vibrometer DASH SSS Dexterity 
Small 
Objects 
Test 
Mean (SD) 6.36 (7.62) 28.16 (28.66) 35.63 
(18.25) 
3.04 (0.75) 49.17 
(15.74) 
Median 
(25
th
 and 
75
th
 
percentile) 
4.40 (3.38, 
5.90) 
19.00 (10.75, 
39. 
25) 
33.33 
(23.33, 
47.29) 
3.00 (2.45 , 
3.64) 
44.00 (40.00, 
53.00) 
Skewness 
(Standard 
Error) 
4.02 (0.38) 2.56 (0.31) 0.66 (0.28) -0.027 
(0.29) 
2.35 (0.31) 
Kurtosis 
(Standard 
Error) 
17.65 (0.75) 8.03 (0.62) 0.282 (0.56) -0.64 (0.60) 6.62 (0.61) 
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Table 2.3:  Spearman correlation between sensory and symptoms severity scores 
and their functional measures 
Tools Time PSSD 
rs (95%CI) 
Vibrometer 
rs (95%CI) 
SSS 
rs (95%CI) 
DASH Baseline 0.09±0.32 0.13±0.25 0.63±0.14* 
6 weeks 0.31±0.30 0.21±0.27 0.74±0.14* 
12 weeks 0.10±0.27 0.22±0.27 0.76±0.13* 
SSS Baseline 0.22±0.31 0.41±0.25*  
1.0 
 
6 weeks 0.32±0.30* 0.22±0.27 
12 weeks 0.25±0.27 0.35±0.27* 
Dexterity Baseline 0.20±0.31 0.36±0.25* 0.32±0.25* 
6 weeks 0.32±0.30* 0.41±0.27* 0.53±0.21* 
12 weeks -0.02±0.27 0.39±0.27* 0.59±0.20* 
PSSD = Pressure Specified Sensory Device.  DASH = Disability of the Arm, Shoulder, 
and Hand.  SSS = Symptom Severity Scale.    
* Correlation is significant at p<0.05 
Confidence intervals were calculated with http://vassarstats.net/rho.html. 
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Table 2.4:  Information on the ROC curves produced 
 Figure1:  ΔSSS 
n = 62 
Figure 2:  
ΔPSSD 
n=38 
ΔVibrometer 
 
n=55 
External Criterion Failed to sufficiently 
resolve symptoms- 
proceed to surgery 
Failed to sufficiently resolve symptoms – 
based on 
ΔSSS = 0.5 
Cut point for CID 0.50 0.15 undefined 
Area under the 
curve  
0.73 (0.60 – 0.86) 0.46 (0.27-0.64) n/a 
Sensitivity 0.86 0.60 0% 
Specificity  0.54 0.39 100% 
ROC = Receiver Operating Characteristic.  CID = Minimally Clinically Important 
Difference.  ΔSSS = change in SSS scores.  ΔPSSD = change in PSSD scores.  
ΔVibrometer = change in Vibrometer scores.  CID for Vibrometer was undefined because 
all who completed both Vibrometer and SSS did not proceed to surgery.  Non responders 
for Vibrometer were because they did not complete SSS.  
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Table 2.5:  Change scores for the SSS and responsiveness based on proceeding to 
surgery 
SD = Standard Deviation.  PSSD = Pressure Specified Sensory Device.  DASH = 
Disability of the Arm, Shoulder, and Hand.  SSS = Symptom Severity Scale.  CI = 
Confidence Interval  
 N Mean Baseline Score 
(SD) 
Mean Post 
Treatment 
Score (SD) 
Mean 
Change 
(SD) 
SRM 
(95%CI) 
ES 
(95%CI) 
SSS Score 
Overall 
62 3.03 (0.75) 
 
2.70 (0.89) 0.32 (0.64) 0.50 
(±0.24) 
0.67 
(±0.24) 
SSS Score 
Responder
s (Δ ≥ 
0.50) 
22 3.03(0.70) 2.05(0.73) 0.98(0.45) 2.18 
(±0.42) 
1.40  
(±0.42) 
SSS Score 
Non 
Responder
s (Δ < 
0.50) 
39 3.02 (0.79) 
 
3.08 (0.759) 
 
0.06(0.39) 
 
0.15 
(±0.31) 
0.08  
(±0.31) 
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Table 2.6:  Responsiveness for the PSSD, and vibrometer based on CID of change 
score SSS = 0.5 
 N Mean Baseline 
Score (SD) 
Mean Post 
Treatment 
Score (SD) 
Mean 
Change (SD) 
SRM 
(95%CI) 
ES  
(95%CI) 
PSSD 
Responder 
15 4.13 (1.99) 3.83 (3.53) 0.30 (3.26) 0.09 
(±0.51) 
0.08 
(±0.51) 
PSSD Non 
Responder 
23 7.82(9.47) 7.30(15.29) 0.53(13.48) 0.04 
(±0.41) 
0.06  
(±0.41) 
Vibrometer 
Responder 
22 25.55(19.51) 16.64(14.46) 8.91(14.70) 0.61  
(±0.41) 
0.46 
(±0.41) 
Vibrometer 
Non 
Responder 
33 27.39 (32.10) 23.39 (29.89) 4.00 (21.81) 0.18 
(±0.34) 
0.12 
(±0.34) 
SD = Standard Deviation.  SRM = Standardized Response Mean.  ES = Effect Size.  
PSSD = Pressure Specified Sensory Device.  DASH = Disability of the Arm, Shoulder, 
and Hand.  SSS = Symptom Severity Scale.  CI = Confidence Interval.  The overall ES of 
all patients was calculated to indicate the overall response to orthotic intervention; SRM 
and ES were determined for responders and non-responders to indicate responsiveness. 
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2.1:  Receiver Operating Characteristic Curve for Determining the Cut-off Point to 
Determine Responder and Non Responder Subgroups Based on the SSS  
Circle represents cut point for Clinically Important Difference. 
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Figure 2.2:  Receiver Operating Characteristic Curve for Determining the Cut-off 
Point to Determine a Clinical Important Change for the PSSD based on the CID of 
0.5 for the SSS.   
Circle represents cut point for Clinically Important Difference. 
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2.7 Discussion 
The current study provides estimates of self-report and sensory measures used in outcome 
assessment of CTS that support the use of the SSS and Vibrometry. This current study 
demonstrated that the CID of the symptom severity scale is smaller than has been 
previously established with reference to a surgical intervention. 
25
 Previous studies have 
suggested that a one-point difference 
23, 25
 was clinically important; whereas our study 
suggested that a 0.50 change was clinically important.  Since the SSS is a five point scale; 
a one-point difference represents a 20% improvement; whereas 0.5 represents a 10% 
improvement.  These differences can be partially attributed to differences in the effect 
size of the two interventions since we know that surgery provides greater change in 
symptoms compared to conservative management. 
55
 For this reason, it is important to 
establish a CID for conservative management that could be used by therapists when 
assessing the response to orthotic intervention. 
The ROC curve in Figure 1 has shown that the CID for the SSS is 0.5. However, this 
value is much lower than the CID determined by Ozyurekoglu et al, 
23
 which was 1.04.  
Potential differences between the studies may stem from differences in treatment type 
and the severity of cases in both studies.  This current study used orthotic intervention for 
chronic cases of CTS, whereas in Ozyurekoglu et al’s study, 23 cortisone injections were 
used for treatment and the patients were suffering from acute cases of CTS.  In terms of 
the method of reported change, our study used the SSS to measure patient self -reported 
change after determining whether they should proceed to surgery or not.  Ozyurekoglu et 
al 
23
 calculated the CID for the SSS based on a global rating of change as the external 
anchor for patients to determine improvement.  The Global Rating of Change has been 
criticized because of recall bias from the patient, 
56
 which may overestimate or 
underestimate the effect of the treatment.  Our study determined the CID for the SSS 
based on the anchor of proceeding to surgery which combines a shared decision by both 
clinician and patient.  We also used distribution-based methods to illustrate 
responsiveness, which has shown that the SSS is responsive to clinical change (Table 5).   
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This study supports the discriminative ability of the SSS, although there are limitations 
inherent in the measurement properties of the SSS, and in this study.  The estimate of 
CID at 0.5 is subject to imprecision as the lower end of the interval is below 0.75, 
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although the confidence interval indicates discrimination may be as high as 0.86.   The 
AUC indicates that the SSS would be more useful than the PSSD or the Vibrometer for 
discriminating patients with a CID.  In practice, it would be useful to set treatment goals 
to achieve a CID of 0.5 on the SSS or greater.  However, since the specificity of this cut-
off was lower than sensitivity, therapists should expect some patients who improve more 
than 0.5 and would still proceed to surgery despite having improved symptoms (Table 5 
and Table 6).  The tool’s CID has a higher probability to send a patient toward surgery 
rather than not.           
Our study also had used the external criteria of proceeding to surgery rather than using a 
global rating of change 
23
 compared to Ozyurekoglu et al’s study.   The external criterion 
of proceeding to surgery was decided by a clinician on the presentation of symptoms 
which patients still experienced despite orthotic intervention.  However, patients may still 
choose not to go for surgery despite when a clinician is in favour of surgery.  The SSS 
was used as an external criteria for the PSSD because the SSS is a self -reported and 
disease specific outcome measure, which would a patient to have a role within the 
decision making process of deciding or not to proceed to surgery under a standardized 
process.  The global rating of change is subject to recall bias and variability 
57, 58
 by the 
patient, and it may not accurately determine the best clinical decision for the patient.  The 
SSS overcomes the issues of reliability and recall bias that the global rating of change 
may have.  This study incorporates both clinician’s and patient’s input in the treatment 
process of determining the clinically important difference on the SSS.   
Comparing the performance of our two sensory tests, we suggest that the Vibrometer 
scores provided more clinically useful indicators than did the PSSD.  The Vibrometer 
was more responsive based on both anchor and distribution based estimates of 
responsiveness.  The correlations between measures were more consistent with the 
expected relationships of sensory function to hand function for the Vibrometer in 
comparison to the PSSD.  The PSSD and Vibrometer did not discriminate to the extent 
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thought useful in clinical practice; in fact the PSSD was no better than chance because 
the area under the ROC curve was crossing the 0.5 mark (Table 5 and 6).  The 
Vibrometer did not provide a defined cut score, as all patients had improved at least 0.5 
on the SSS.  A larger sample size of patients could be recruited for future studies to 
increase the number of failures from orthotic intervention to allow for a cut score to be 
determined.  Clinicians should be aware that the PSSD and Vibrometer may not be useful 
for clinical decisions about whether their patients have made clinically important 
improvements.  Since that the Vibrometer shows more promise, the next steps would be 
to perform more detailed analysis about the use of Vibrometer scores in clinical decision-
making.  Although we did not find the PSSD useful for evaluating clinical change, others 
have reported it useful in diagnosis of nerve entrapment syndromes. 
59
 The PSSD is a 
very sensitive tool for diagnosing CTS, cubital tunnel syndrome, tarsal tunnel syndrome, 
and common peroneal nerve entrapment, all having highest sensitivity possible (100%), 
but low specificity ranging from 0 – 33%.  59  The PSSD was reported to be more 
sensitive than standard electrodiagnosis, which is a standard method for diagnosing 
neuropathy (which had sensitivity ranging between 37% - 89% depending on the type of 
neuropathy.) 
59
 The PSSD would be able to detect neuropathies even when the standard 
method cannot in patients suspected of having neuropathy.   
The correlation between the sensory measures and the DASH did not match our a priori 
expectations.  We expected that sensory function should contribute to hand function and 
be reflected in this measure because the DASH has questions specifically regarding 
numbness and tingling, and it has been validated for the CTS population. 
60
  Correlations 
were generally higher with the SSS which suggest that the SSS is a better indicator of 
sensory nerve function than the DASH.  In addition, the DASH does not contain specific 
questions on touch or vibration threshold, so this may contribute to the low correlations 
between sensory threshold tests and DASH.       
The SSS was found to have moderate correlations with dexterity small objects test, and 
good to excellent correlations 
61
 with DASH.  Our correlation between the SSS and 
DASH is similar to the results found in a study on the validation of the Turkish version of 
the Quick DASH to the SSS in patients with CTS. 
60
 This paper found that the Quick 
42 
 
DASH had a high correlation between the disability/symptom and work subscales with 
the SSS (r = 0.63-0.68).  Our current study and the study by Dogan et al 
60
 both reinforce 
that the DASH is a valid tool for the evaluating patients with CTS.  In terms of the 
correlation between dexterity and symptom severity, the moderate correlation indicates a 
proportional relation between symptoms severity and the impairment to hand dexterity.  
Our study had similar findings to a kinematic study 
61
 comparing the variability in the 
precision of pinching tasks in 16 age and gender matched patients with CTS and healthy 
controls.  Gehrmann et al 
61
 found that patients with CTS had more variability in their 
pinching movements compared to the controls.  Regardless of methodology, both our 
studies suggest that CTS impairs hand dexterity.      
Our study results had some limitations.  Most important of these is that the sensory tests 
were performed by a trained experienced independent evaluator, not by a hand therapist. 
Independent evaluators may have been less skilled than hand therapists in sensory testing.  
However, even experienced hand therapists do not always agree on touch threshold 
measures in CTS patients. 
16, 17
 The PSSD is a hand-held device and may be more subject 
to error than the Vibrometer.  Brakel et al 
62
 found that evaluator experience in sensory 
testing can influence inter-tester reliability.  The study examined the inter tester reliability 
in sensory testing between five physiotechnicians and nurse/paramedical workers in a 
sample of patients with leprosy.  Physiotechnicians had significantly higher weighted 
kappa values with touch threshold testing (kappa = 0.98 versus 0.89) compared to whole 
group. 
62
 This difference might be explained because physiotechnicians were more 
experienced in sensory testing than nurse/paramedical workers. 
62
 In contrast, the 
Vibrometer is an automated ramped protocol and uses multiple applications of a vibrating 
stimulus.  Hence, skill may have been less importance for this tool, so that the random 
error may be reduced.   Our study also had small groups tested for each sensory tool as a 
limitation to the study.  We had some tests which were not completed for each patient 
when they came for their visit.  These small sample sizes may have resulted in increased 
type II error of the correlations found between the sensory tools and functional measures.  
For example, the PSSD was unable to achieve a significant correlation with other tools.  
We would need to be more consistent during data collection to complete outcome 
measures for all patients coming into the study.   
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2.8 Conclusion 
This study suggests that the Vibrometer is a better choice for evaluating sensation to 
represent overall hand function.  The CID of 0.5 on the SSS from orthotic intervention 
may be useful for setting treatment goals.  Sensory tools should not be used in isolation to 
make decisions about clinical improvement in CTS.  Despite the common use of sensory 
evaluation, there remains a large gap in our knowledge of the clinical measurement 
properties of different tools and test protocol variations.  Future studies should address 
how clinical decisions are made based on sensory measures and whether sensory tools are 
important measures in evaluating the prognosis of patients.   
44 
 
2.9 References 
1. Atroshi I, Gummesson C, Johnsson R, Ornstein E, Ranstam J, Rosén I. Prevalence of 
carpal tunnel syndrome in a general population. JAMA: the journal of the American 
Medical Association. 1999;282:153.  
2. Luckhaupt SE, Dahlhamer JM, Ward BW, Sweeney MH, Sestito JP, Calvert GM. 
Prevalence and work-relatedness of carpal tunnel syndrome in the working population, 
United States, 2010 national health interview survey. Am J Ind Med. 2012.  
3. Tanaka S, Wild DK, Seligman PJ, Halperin WE, Behrens VJ, Putz-Anderson V. 
Prevalence and work-relatedness of self-reported carpal tunnel syndrome among U.S. 
workers: Analysis of the Occupational Health Supplement data of 1988 National Health 
Interview Survey. Am J Ind Med. 1995;27:451-470.  
4. Zakaria D. Rates of carpal tunnel syndrome, epicondylitis, and rotator cuff claims in 
Ontario workers during 1997. Chronic Dis Can. 2004;25:32-39.  
5. Zakaria D, Robertson J, MacDermid J, Hartford K, Koval J. Work‐related cumulative 
trauma disorders of the upper extremity: Navigating the epidemiologic literature. Am J 
Ind Med. 2002;42:258-269.  
6. Feuerstein M, Miller VL, Burrell LM, Berger R. Occupational upper extremity 
disorders in the federal workforce: prevalence, health care expenditures, and patterns of 
work disability. Journal of Occupational and Environmental Medicine. 1998;40:546.  
45 
 
7. Werner RA, Andary M. Carpal tunnel syndrome: pathophysiology and clinical 
neurophysiology. Clinical Neurophysiology. 2002;113:1373-1381.  
8. Kerwin G, Williams CS, Seiler 3rd J. The pathophysiology of carpal tunnel syndrome. 
Hand Clin. 1996;12:243.  
9. Gerritsen AAM, de Vet HCW, Scholten RJPM, Bertelsmann FW, de Krom MC, 
Bouter LM. Splinting vs surgery in the treatment of carpal tunnel syndrome. JAMA: the 
journal of the American Medical Association. 2002;288:1245.  
10. Gerritsen AA, de Krom MC, Struijs MA, Scholten RJ, de Vet HC, Bouter LM. 
Conservative treatment options for carpal tunnel syndrome: a systematic review of 
randomised controlled trials. J Neurol. 2002;249:272-280.  
11. Gerritsen AA, de Vet HC, Scholten RJ, van Tulder MW, Bouter LM. Enabling meta-
analysis in systematic reviews on carpal tunnel syndrome. J Hand Surg Am. 2002;27:828-
832.  
12. Gerritsen AA, Uitdehaag BM, van Geldere D, Scholten RJ, de Vet HC, Bouter LM. 
Systematic review of randomized clinical trials of surgical treatment for carpal tunnel 
syndrome. Br J Surg. 2001;88:1285-1295.  
13. Gerritsen AAM, De Vet HCW, Scholten RJPM, Bertelsmann FW, De Krom 
MCTFM, Bouter LM. Greater clinical effects on carpal tunnel syndrome with surgery 
than with splinting; results of a randomised clinical trial. Ned Tijdschr Geneeskd. 
2002;146:2153-2156.  
46 
 
14. Rempel D, Evanoff B, Amadio PC, et al. Consensus criteria for the classification of 
carpal tunnel syndrome in epidemiologic studies. Am J Public Health. 1998;88:1447.  
15. MacDermid J. Accuracy of clinical tests used in the detection of carpal tunnel 
syndrome: a literature review. Journal of Hand Therapy. 1991;4:169-176.  
16. MacDermid JC, Kramer JF, Roth JH. Decision making in detecting abnormal 
Semmes-Weinstein monofilament thresholds in carpal tunnel syndrome. J Hand Ther. 
1994;7:158-162.  
17. MacDermid J, Kramer J, McFarlane R, Roth J. Inter-rater agreement and accuracy of 
clinical tests used in diagnosis of carpal tunnel syndrome. Work. 1997;8:37-44.  
18. MacDermid JC, Doherty T. Clinical and electrodiagnostic testing of carpal tunnel 
syndrome: a narrative review. J Orthop Sports Phys Ther. 2004;34:565-588.  
19. MacDermid JC, Wessel J. Clinical diagnosis of carpal tunnel syndrome: a systematic 
review. Journal of Hand Therapy. 2004;17:309-319.  
20. Thonnard JL, Saels P, den Bergh PV, Lejeune T. Effects of chronic median nerve 
compression at the wrist on sensation and manual skills. Experimental brain research. 
1999;128:61-64.  
21. Bell-Krotoski J, Weinstein S, Weinstein C. Testing sensibility, including touch-
pressure, two-point discrimination, point localization, and vibration. Journal of hand 
therapy: official journal of the American Society of Hand Therapists. 1993;6:114.  
47 
 
22. Levine DW, Simmons BP, Koris M, et al. A self-administered questionnaire for the 
assessment of severity of symptoms and functional status in carpal tunnel syndrome. 
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME-. 1993;75:1585-
1585.  
23. Ozyurekoglu T, McCabe SJ, Goldsmith LJ, LaJoie AS. The minimal clinically 
important difference of the Carpal Tunnel Syndrome Symptom Severity Scale. J Hand 
Surg Am. 2006;31:733-8; discussion 739-40.  
24. Boyd KU, BING SGAN, Ross DC, Richards RS, Roth JH, MacDermid J. Outcomes 
in carpal tunnel syndrome: symptom severity, conservative management and progression 
to surgery. Clinical and investigative medicine. 2005;28:254-260.  
25. Kim JK, Jeon SH. Minimal clinically important differences in the Carpal Tunnel 
Questionnaire after carpal tunnel release. J Hand Surg Eur Vol. 2012.  
26. Thonnard JL, Saels P, den Bergh PV, Lejeune T. Effects of chronic median nerve 
compression at the wrist on sensation and manual skills. Experimental brain research. 
1999;128:61-64.  
27. Dellon AL, Keller KM. Computer-assisted quantitative sensorimotor testing in 
patients with carpal and cubital tunnel syndromes. Ann Plast Surg. 1997;38:493.  
28. Hubbard MC, MacDermid JC, Kramer JF, Birmingham TB. Quantitative vibration 
threshold testing in carpal tunnel syndrome: analysis strategies for optimizing reliability. 
J Hand Ther. 2004;17:24-30.  
48 
 
29. Alfonso C, Jann S, Massa R, Torreggiani A. Diagnosis, treatment and follow-up of 
the carpal tunnel syndrome: a review. Neurol Sci. 2010;31:243-252.  
30. Massey EW. Carpal tunnel syndrome in pregnancy. Obstet Gynecol Surv. 
1978;33:145-148.  
31. Mondelli M, Rossi S, Monti E, et al. Prospective study of positive factors for 
improvement of carpal tunnel syndrome in pregnant women. Muscle and Nerve. 
2007;36:778-783.  
32. Stolp-Smith K, Pascoe MK, Ogburn P, J. Carpal tunnel syndrome in pregnancy: 
frequency, severity, and prognosis. Arch Phys Med Rehabil. 1998;79:1285-1287.  
33. Tucker AT, White PD, Kosek E, et al. Comparison of vibration perception thresholds 
in individuals with diffuse upper limb pain and carpal tunnel syndrome. Pain. 
2007;127:263-269.  
34. Leite J, Jerosch-Herold C, Song F. A systematic review of the psychometric 
properties of the Boston Carpal Tunnel Questionnaire. BMC musculoskeletal disorders. 
2006;7:78.  
35. Katz JN, Gelberman RH, Wright EA, Lew RA, Liang MH. Responsiveness of self-
reported and objective measures of disease severity in carpal tunnel syndrome. Med Care. 
1994;32:1127-1133.  
49 
 
36. Chatterjee JS, Price PE. Comparative responsiveness of the Michigan Hand 
Outcomes Questionnaire and the Carpal Tunnel Questionnaire after carpal tunnel release. 
J Hand Surg Am. 2009;34:273-280.  
37. Greenslade JR, Mehta RL, Belward P, Warwick DJ. Dash and boston questionnaire 
assessment of carpal tunnel syndrome outcome: What is the responsiveness of an 
outcome questionnaire? J Hand Surg. 2004;29 B:159-164.  
38. McConnell SG, Beaton DE, Bombardier C. The DASH Outcome Measure User's 
Manual First ed. Toronto, Ontario: Institute for Work & Health; 1999.  
39. Kotsis SV, Lau FH, Chung KC. Responsiveness of the Michigan Hand Outcomes 
Questionnaire and physical measurements in outcome studies of distal radius fracture 
treatment. J Hand Surg Am. 2007;32:84-90.  
40. Beaton DE, Katz JN, Fossel AH, Wright JG, Tarasuk V, Bombardier C. Measuring 
the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the 
Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. J 
Hand Ther. 2001;14:128-146.  
41. MacDermid JC, Mulè M. Concurrent validity of the NK hand dexterity test. 
Physiotherapy Research International. 2001;6:83-93.  
42. Turgeon TR, MacDermid JC, Roth JH. Reliability of the NK dexterity board. J Hand 
Ther. 1999;12:7-15.  
50 
 
43. Portney LG, Watkins MP, eds. Foundations of Clinical Research Applications to 
Practice Second Edition ed. Upper Saddle River, New Jersey: Prentice Hall Health; 
2000.  
44. Stern LD. A Visual Approach to SPSS for Windows. 2nd ed. Pearson; 2010.  
45. Gardner RC. Psychological Statistics using SPSS for Windows. Prentice Hall Upper 
Saddle River, NJ; 2001.  
46. Finch E, Dina. Brooks, Stratford PW. Physical rehabilitation outcome measures. . 
2002.  
47. Worster A, Fan J, Upadhye S. Understanding receiver operating characteristic (ROC) 
curves. CJEM. 2006;8:19-20.  
48. Liang H-, Wang Y-, Pan S-, Wang T-, Huang T-. Asymptomatic Median 
Mononeuropathy Among Men With Chronic Paraplegia. Arch Phys Med Rehabil. 
2007;88:1193-1197.  
49. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR. Methods to explain the 
clinical significance of health status measures. Mayo Foundation; 2002;77:371-383.  
50. Yost KJ, Eton DT. Combining distribution-and anchor-based approaches to determine 
minimally important differences. Eval Health Prof. 2005;28:172-191.  
51. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health 
status. Med Care. 1989:178-189.  
51 
 
52. Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative measurement 
efficiency and sensitivity of five health status instruments for arthritis research. Arthritis 
& Rheumatism. 2005;28:542-547.  
53. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum; 
1988.  
54. Cohen J. Statistical power analysis for the behavioral sciences. . 1977.  
55. Shi Q, MacDermid JC. Is surgical intervention more effective than non-surgical 
treatment for carpal tunnel syndrome? a systematic review. Journal of orthopaedic 
surgery and research. 2011;6:1-9.  
56. Chung KC. The Minimal Clinically Important Difference of the Carpal Tunnel 
Syndrome Symptom Severity Scale. J Hand Surg. 2006;31:739-740.  
57. Kamper SJ, Maher CG, Mackay G. Global rating of change scales: a review of 
strengths and weaknesses and considerations for design. The Journal of manual & 
manipulative therapy. 2009;17:163-170.  
58. Herrmann D. Reporting Current, Past, and Changed Health Status: What We Know 
about Distortion. Med Care. 1995;33:AS89-AS94.  
59. Tassler P, Dellon A. Correlation of measurements of pressure perception using the 
pressure-specified sensory device with electrodiagnostic testing. Journal of Occupational 
and Environmental Medicine. 1995;37:862.  
52 
 
60. Dogan SK, Ay S, Evcik D, Baser O. Adaptation of Turkish version of the 
questionnaire Quick Disability of the Arm, Shoulder, and Hand (Quick DASH) in 
patients with carpal tunnel syndrome. Clin Rheumatol. 2011;30:185-191.  
61. Gehrmann S, Tang J, Kaufmann RA, Goitz RJ, Windolf J, Li Z-. Variability of 
Precision Pinch Movements Caused by Carpal Tunnel Syndrome. J Hand Surg. 
2008;33:1069-1075.  
62. Van Brakel W, Khawas I, Gurung KS, Kets C, Van Leerdam M, Drever W. Intra-and 
inter-tester reliability of sensibility testing in leprosy. International journal of leprosy and 
other mycobacterial diseases: official organ of the International Leprosy Association. 
1996;64:287.  
 
 
 
53 
 
Chapter 3  
3 A Pilot Study to Determine the Effect of Cell Phone Texting on Patients with 
Carpal Tunnel Syndrome (CTS) 
Cheung DKM, MacDermid JC, Grewal R 
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3.1 Introduction 
Text messaging is a common method of communication.  Between the years 2001 to 
2011, there was a substantial increase in the number of cell phone subscribers and text 
messages sent in the United States of America. 
1
 A recent study examined the nature of 
cell phone usage over 2001-2011 and found at that in 2001, there were128.4million cell 
phone subscribers and 252.8 million text messages sent per month in U.S. 
1
 Ten years 
later, the number of cell phone subscribers has increased to 331.6 million and 
193.1billion text messages were sent per month.  In 2011, an average of 20 text messages 
were sent per day per user; although there is wide variability in usage. 
1
  
  Case studies have reported that many adolescents and adults have suffered from injuries 
sustained from prolonged thumb texting activity. 
2, 3
 Case studies and observational 
studies have indicated injuries such as joint arthritis, tendonitis in the thumb, 
4
 and 
tenosynovitis  suggesting a link to  excessive texting. 
3
 A biomechanical study has 
indicated that people suffering from pain and numbness in the upper extremity (neck, 
arm, or hand) had lower muscle activity in the trapezius, but higher muscle activity in the 
thumb during a texting activity compared to non-symptomatic individuals. 
5
  This 
suggests an etiologic basis for hand pathology with excessive texting. Other studies have 
also indicated physiological changes from texting in healthy individuals, such as 
increased trunk stability, and changes in breathing patterns. 
6
 However, it is not clear how 
patient populations such as people with Carpal Tunnel Syndrome (CTS) are affected by 
texting. It might be assumed that pre-existing pathology increases the potential for 
adverse effects of texting. It is also unclear how the performance of patients with CTS 
might be impaired or different from individuals without CTS.   
Carpal Tunnel Syndrome (CTS) is a common neuropathy associated with vascular, 
sensory, and motor impairments in the hand and the wrist. 
7, 8
 Classical symptoms for the 
diagnosis of CTS include:  altered sensation, numbness, tingling, and occasionally pain in 
the hand. 
7, 8
 Studies suggest that these symptoms are aggravated from the increase in 
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carpal tunnel pressure within the carpal tunnel structure, 
9-11
 which compresses 
anatomical structures 
12
 against the median nerve.  Carpal tunnel pressure varies 
depending on the posture of the wrist (flexion, extension, radial deviation, or ulnar 
deviation), forearm posture (pronated, semi-pronated, or supinated), and the finger 
posture (closed, pinch, straight, or relaxed). 
7
 
9
 Carpal tunnel pressures are the highest at 
extreme ranges of motion for the wrist depending on the postures of the fingers, and 
forearm. 
13
  Cell phone texting is commonly performed with the thumbs and may be 
characterized by both wrists in ulnar deviation and the fingers are in a closed or pinching 
position around the cell phone device.  The thumbs perform repetitive motion of pressing 
against keys, while the other digits are flexed and grip the device.   
Understanding the impact of texting on a patient population with CTS would inform our 
understanding about the nature of patients’ symptoms with activity; and help clinicians 
make recommendations about the use of cell phones. Therefore the purposes of this study 
were:  
1. To determine the feasibility of conducting a large cohort study examining long-
term risks of texting in patients with CTS and normal age-matched controls 
2. To establish the potential immediate effects that might be anticipated on 
superficial blood flow, sensory threshold and symptoms  in response to  texting 
3. To determine difference in texting performance between patients with CTS and 
normal age-matched controls 
 
3.2 Hypotheses: 
1. We anticipate that feasibility will be demonstrated: 
a. If outcome measure variability suggests that a long–term cohort study 
could be conducted with less than 300 subjects in total 
b. If exclusion rates did not exceed  60% 
c. If participation rates exceeded 20% 
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d. The rate of withdrawal does not exceed 20% 
2. Patients with CTS will have significantly lower superficial blood flow, higher 
touch threshold, and worse symptoms than healthy controls.  Significant changes 
will occur to measurement outcomes immediately after texting for patients only.  
3. Patients with CTS will text significantly fewer characters, shorter duration, and 
slower average texting speed compared to healthy controls.   
 
3.3 Materials and Methods: 
Patients with known CTS were recruited from a tertiary health care setting was confirmed 
by one of three hand surgeons using clinical tests and results from electrodiagnostic 
studies. Patients were informed about the study either through the treating surgeon or 
through administrative staff.  Patients were excluded from the study if they had one of the 
following exclusion criteria:   
 Received previous surgery for CTS 
 Insulin dependent Diabetes  
 Younger than 18 years old or older than 65 years old  
 Recent or current injury to the upper extremity, including neck – muscle, bone, or 
nerve injury (within the past year)  
 Osteoarthritis  
 Heart Condition 
 Ongoing cancer 
 CTS with ongoing pregnancy   
 Vascular problems with the hands or arms (i.e. Raynaud’s Syndrome)  
57 
 
 
Age and gender matched persons without CTS were also recruited as controls for the 
study.  The controls were recruited through posters advertisement in the hospital and 
through word of mouth to hospital staff (physiotherapists, occupational therapists, and 
administrative staff), and graduate students.  When controls were recruited by word of 
mouth, the primary investigator explained the study at staff meetings to inform and guide 
staff to decide whether they would be interested and/or eligible for the study.  Exclusion 
criteria were explained to staff to advise them to whether they were eligible for the study 
or not.  Hard copies describing the study, contact information, and a sign-up sheet were 
given to staff.  Patients were matched with controls recruited for the study within an age 
range of ± 5 years.  Persons who were 65 years old were matched with a control between 
ages 60 to 65 years old to stay within the age bracket of the study.  Patients were matched 
to age and gender matched controls to allow for matched comparisons and improve 
statistical power.  Recruitment of the controls was based on the same exclusion criteria as 
patients with CTS to participate in the study.  Only one visit was required for the study 
for each participant.  Each participant was asked not to consume any caffeine (i.e. tea or 
coffee) 4 hours before the study.  All participants who participated in the study 
understood the letter of information and provided signed consent to participate in the 
study. 
3.4 Outcome Measures:   
TIVI (Tissue Viability Imaging) 600 polarization spectroscopy camera (version 7.4 
Wheelsbridge AB, Linköping, Sweden): TIVI software was used to quantify red blood 
cell concentration on the palmar side of the hand using a digital camera (Canon Rebel 
EOS model 450D, Japan) with a polarization lens.  The camera was supported by a multi-
jointed metal arm provided by Wheelsbridge and the arm was secured to a desk.  The 
camera was adjusted to point downwards towards the surface of the desk.  A royal blue 
coloured file folder was placed under the camera to fill the camera view.  An outline was 
drawn on the blue folder to standardize hand positioning for the left and right hand.  Each 
participant was required to place their hand in line with the outline with hand(s) in 
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supinated position with the skin grooves for each interphalangeal joint of the fifth 
phalange in line with specific markings on the hand outline.  The participants were asked 
to keep their palms in an open position with all fingers and their thumb in line with each 
other.  Each image was captured with the polarized lens set at the cross polarization 
setting and the camera was positioned at a distance between 200mm to 300mm from the 
participant’s hand.  Image quality was set to medium normal.  One photo was taken every 
5 seconds and uploaded into the attached laptop computer.  The camera has a light 
penetration depth between 400 to 500 micrometers. 
14
 
Once the images were captured, the TIVI images were processed using the TIVI 
software.  For each participant, one image at baseline and at each follow up point (0, 2, 5, 
and 10 minute(s) after texting) were used for processing and analysis, for a total of 5 
images per participant.  If the participant had bilateral CTS, only one hand (left or right) 
was processed and analyzed for this study.  For patients with bilateral CTS, the hand with 
more severe symptoms as defined by the SSS was used for processing and analyzed.  If 
only one side was affected with CTS, that hand would be used. The same sided hand was 
processed for matched controls.   Regions of Interest (ROI’s) were selected at the distal 
pulps of each finger and the sum of the ROI’s represented total blood flow in the hand.  
Curve tracker was used to produce a spread sheet categorizing the magnitudes of red 
blood cell concentration by the selected ROI’s.  Values for the TIVI are measured by 
Arbitrary Units (A.U.).  Data was exported from the TIVI software into Microsoft Excel 
2007 spreadsheets via Curve Tracker and then imported into SPSS version 19.0 for 
analysis.  The TIVI has been validated for construct validity to measure superficial red 
blood cell concentration with in vitro fluid models and computer simulations. 
14, 15
 The 
models performed in vitro demonstrated that the TIVI software was able to accurately 
calculate the oxygen saturation level of 91.5%, which is within the physiological range of 
oxygen saturation within blood. 
14
  The TIVI has been shown to be sensitive to change 
during blood occlusion testing, 
15
 and drug testing on skin. 
16
  The TIVI has demonstrated 
inter-laboratory reliability. 
17
 When 4 TIVI units were tested in two different sites with 
identical protocols, the average systematic drift was <1.02% for all 4 units under the 
same protocol. 
17
  When the same protocol was repeated 2 months later, TIVI 
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demonstrated test retest reliability. 
17
  The maximum percentage deviation ranged from 
0.74% to 1.7%. 
17
 
Pressure Specified Sensory Device (PSSD) (NK Biotechnical Corporation, 
Minneapolis, MN, USA): This computerized tool measures touch threshold or the 
amount of pressure required to elicit a response on the distal pulp of the thumb.  The 
PSSD was collected with the participant seated at the testing station and with the 
participant resting his hand in a supinated position on a piece of foam and asked to close 
his eyes.  The tester would gently touch the pulp of the thumb at 5 different points with 
the PSSD device and the participant would respond when they detected the stimuli by 
pushing a trigger in the other hand.  The highest and lowest values were discarded and 
the average of three values was recorded as the measure of touch threshold.  The PSSD 
has been evaluated for reliability (r= 0.95) and inter-rater reliability in patients with 
neuropathy for one point static testing (r= 0.93 - 1.00). 
18
 
Numeric Rating Scale for Pain: This scale allowed patients to rate their measured pain 
in the hand at a specific point in time.  The numeric rating scale ranges from 0 to 10.  
Participants were asked to first rate their pain between 0 (not experiencing the symptom 
at all) to 10 (worst possible rating) verbally.  The first author (DC) would mark down the 
rating to the corresponding scale.  For bilateral CTS cases, the hand chosen for analysis 
was the side which had greater symptom severity based on the patient’s concern, and 
from patient lists.  For unilateral cases, the affected side was tested.  For controls, the side 
tested was matched to the patient’s same side.  The numeric pain rating scale has been 
validated for examining changes in pain qualities in CTS after treatment. 
19
  
Numeric Rating Scale for Numbness: Numeric rating scales for measuring numbness 
have been suggested to be valid for measuring the severity of Carpal Tunnel Syndrome. 
20, 21
 The numeric rating scale ranges from 0 to 10.  Participants were asked to first rate 
the amount of numbness they experienced in their hand between 0 (not experiencing the 
symptom at all) to 10 (worst possible rating) verbally.  The first author (DC) would mark 
down the rating to the corresponding scale. For bilateral CTS cases, the hand chosen for 
analysis was the side which had greater symptom severity based on the patient’s concern, 
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and from patient lists.  For unilateral cases, the affected side was tested.  For controls, the 
side tested was matched to the patient’s same side.  The numeric rating scale for 
numbness is a component of the PQAS (Pain Quality Assessment Scale), and measures 
sensibility impairment, similar to the Ten test.  The PQAS is a 20 item scale which allows 
the patient to rate various components of pain between 1 (none) to 10 (worst).  The 
numeric rating scale for numbness in the PQAS has been shown to be a responsive tool 
for measuring change in numbness (ES = 1.27) after treatment for CTS with injection and 
lidocaine patch, separately. 
19
 The Ten test is a sensory test where patients rate the extent 
of sensory impairment between 1 (impaired) to 10 (normal or best sensibility).  The test 
retest reliability of the numeric rating scale for numbness has not been verified, but the 
Ten test 
22
 has been verified to show inter-rater reliability (ICC = 0.91) for 49 patients 
with peripheral nerve disorders.     
Numeric Rating Scale for Fatigue: The purpose of the numeric rating of fatigue is to 
rate perceived fatigue after an activity. The numeric rating scale ranges from 0 to 10.  
Participants were asked to first rate the amount of fatigue they experienced in their hand 
between 0 (not experiencing the symptom at all) to 10 (worst possible rating) verbally.  
The first author (DC) would mark down the rating to the corresponding scale.  For 
bilateral CTS cases, the hand chosen for analysis was the side which had greater 
symptom severity based on the patient’s concern, and from patient lists.  For unilateral 
cases, the affected side was tested.  For controls, the side tested was matched to the 
patient’s same side.    The numeric rating scales for fatigue and numbness have been used 
in new patients with cancer receiving chemotherapy 
23
 for rating fatigue and numbness 
affecting the whole body.  We are uncertain if the numeric rating scale for fatigue is valid 
and reliable for patients with CTS after performing an activity because this application 
has not been tested, but numeric rating of pain and other symptoms have been 
consistently high across numerous contexts.   
Symptom Severity Scale (SSS): The SSS is a self-report questionnaire designed for 
measuring symptoms experienced by patients with CTS. 
24
 The SSS is composed of 11 
questions each rated 1 through 5 that measures symptoms experienced in a typical 24 
hour period within the past 2 weeks.  Respondents rate the severity of CTS-related 
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symptoms and disability where a rating of 1 indicated that there was no symptom at all, 
and 5 represented the worst symptom experienced. 
24
  Rating the scale was done for both 
the left and right hand to determine which hand was worse.  The mean score was 
calculated for each hand and the hand with the higher score was used as the final score 
for calculations in this study.  The SSS has been assessed and found to be valid for face, 
content, and construct validity in measuring clinically relevant change in patients with 
CTS. 
24
 The SSS was used to determine which hand had more severe symptoms in 
bilateral cases.  The SSS has also been shown to be reliable 
24, 25
 and responsive. 
26, 27
 
Texting Performance: For texting performance, we wanted to observe the number of 
characters texted, duration texted (seconds), and the texting speed (characters/second).  
The number of characters texted was counted for each participant.  This value was the 
sum of the number of characters and the number of spaces entered into the cell phone 
during the visit for each participant.  Each text message was sent to an email account and 
then copied to a word processing software (Microsoft Office 2010).  The number of 
characters was counted using a count feature within word processing software to count all 
characters and spaces in the text messages.  The duration each participant was able to text 
was timed with a digital timer in seconds.  The timer counted down from 15 minutes.  
The duration of texting recorded was when the time was up or if the patient requested to 
stop texting early because of symptoms; whichever was first.   The texting speed was 
calculated by dividing the number of characters and spaces entered into the cell phone it 
by the duration in seconds which the participant was texting.   
3.5 Procedure: 
The letter of information was explained to each participant and consent was provided.  
Then, each participant provided the following demographic information:  age, gender, 
duration of symptoms (for patients only), which hand was affected (for patients only), 
hand dominance (left or right), whether the injury was involving Workplace Safety and 
Insurance Board (WSIB), and familiarity with texting on a QWERTY phone (yes or no).  
Then the SSS was completed.  Data for the TIVI, the numeric rating scale for pain, 
fatigue, and numbness, and the PSSD were collected at rest (in this order). 
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Participants were then asked to perform a standardized texting task.  Immediately after 
texting, data for the TIVI, PSSD, and the Numeric Rating Scale for Pain, Fatigue, and 
Numbness were collected.  These outcome measures were measured again at 2 minutes, 5 
minutes, and 10 minutes after texting.    
3.6 Intervention:   
During the texting activity, patients and controls were asked to text with a cell phone 
while seated and to use only their thumbs to text in their response to questions from a 
questionnaire.  The same cell phone was used for all the participants and all participants 
used the QWERTY key pad on the cell phone.  The questionnaire was composed of 60 
questions which allowed for open ended responses.  The questionnaire asked patients 
general questions regarding how participants learn about the study, or where did they 
plan to go after the study.  The questionnaire was designed for this study and is not a 
standard part of patient care.  Participants were asked to place a space between each word 
they entered.  After each question, participants were asked to place a period and then 
proceed to the next question. This period was used by the authors to separate each 
response in the questionnaire. Since the cell phone had a limit of 600 characters per text 
message, once text message reached 600 characters, each text message was sent to the 
first author’s email account.  After each message was successfully sent, the participant 
continued texting from the questionnaire.  Each participant performed the texting activity 
for a maximum time of 15 minutes.  If the activity was too uncomfortable, the time of 
pain free typing was recorded.  If participants completed answering the entire 
questionnaire, the participants were asked to complete the questionnaire again until 15 
minutes had elapsed from the start of the texting activity. The cell phone was set to 
prevent word prediction to complete the replication of the script.   
Cell Phone Model: The cell phone that was used for the study was a LG Rumour 2 (LG 
Corp, Seoul, South Korea) which has a sliding QWERTY touch key pad for entering text 
message.  A QWERTY key pad is type of key pad interface where the top left letter row 
read from left to right is Q-W-E-R-T-Y.  Only the QWERTY key pad was used in this 
study.  A T9 key pad which was also available on the phone (but not used for this study)  
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is a key pad with 9 keys which has a predictive feature for letters or numeric characters.  
The predictive word feature for the phone was turned off. 
Table 3.1:  Cell Phone Specification 
Company and Model LG Rumour 2  
Dimensions (height x width x depth)  11.2 x 5.3 x 1.8 cm in QWERTY 
mode)  
Weight  120g 
Resolution  240 x 320 pixels  
Keyboard Input Text  QWERTY or T9 
Maximum character and space storage 
per text message 
600  
 
3.7 Analysis: 
Objective 1:  Sample Size Calculation for Feasibility Study.  Sample size for future 
cohort studies was calculated based on the observed variability of the measures in this 
study trial.  The sample size was determined using a sample size calculator based on a 2 
sided test to determine a significant difference between the patient and control group as 
independent variables 
28
 from http://stat.ubc.ca/~rollin/stats/ssize/n2.html at a power of 
80% with α = 0.05.  The value for x1 was a pooled score of patient and control scores at 
baseline, and x2 was the sum of x1 and 20% 
29
 of x1 for each outcome measure, to account 
for clinically important change.  The standard deviations for the calculator were derived 
from each of the 6 outcome measure based on x1 (Table 2).  The minimum sample size 
required for a full study ranged between 16 to 120 patient participants per group 
depending on the outcome measure (Table 4).  The sample size for a full study would 
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depend on which outcome measure(s) will be used.  Statistical significance was 
considered if p<0.05.    
Objective 2 and 3:  Determining Differences within and between Patients and 
Healthy Controls.  Generalized Linear Model (GLM) 
30
 was used to determine if 
patients have different measures of blood flow, sensory threshold, and symptoms 
compared to controls at baseline (compare SSS, TIVI, PSSD, and NRS for pain, fatigue, 
and numbness) at rest and at each follow-up point after texting.  Interactions were 
examined for significance between group and time.  Post hoc analyses were performed 
using Bonferroni Correction for non significant interactions to determine between group 
differences.  Pair wise comparisons 
30
 were used to perform within-group comparisons to 
compare between baseline scores to each of the follow-up scores.  
An analysis of covariance (ANCOVA) 
30
 was performed to compare texting 
performances between patients and controls for the number of characters texted, time 
texted, and texting speed.  Experience with texting was controlled as a covariant.   
Data was checked for normal distribution for each follow up point.  Differences were 
considered significant with p<0.05. 
3.8 Results: 
Seventy one patients were screened for the study using patient lists for 8 months from 
mid January to mid September 2012.  The data were considered normally distributed 
because sample sizes were equal in both groups. 
3132
 Data had minor violations of the 
assumption of circularity and adjustments were made with the Greenhouse-Geisser 
epsilon to the degrees of freedom to correct for this violation. 
32, 33
 No data were missing.  
Demographic information of participants is presented in Table 1.  
Objective 1:  Feasibility of the Research Study.  We had a 21% accrual rate for 
acquiring patients from the potential pool of available subjects, as we successfully 
recruited 15 out of 71 eligible patients.  Thirty nine patients (55% of potential patient 
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participants) were excluded because they did not meet the inclusion criteria (Table 1b) 
(Figure 1).  Twenty two potential patient participants were approached (31%).  Six 
patients refused to participate when approached (Table 1c). Ten patients were not 
approached (Table 1d).  Sixteen patients were recruited for the study, indicating a 73% 
recruitment rate. One patient withdrew from the study, indicating a withdrawal rate of 6% 
(Table 1c).  Thus, fifteen patient participants completed the study.  Fifteen healthy age 
and gender matched controls were also recruited as controls.  The 3 main exclusion 
criteria for excluding patients was because of age (patients were over 65 years old), from 
co-morbidities to upper extremity, or from diabetes (Table 1b)  The main reason potential 
patients refused to participate in the study because they were not interested in the study, 
as they had other commitments after their appointments.  Ten potential patient 
participants were not approached (Figure 1).  The most common reason for not 
approaching potential patient participants were the first author (DC) or administrative 
staff missed the opportunity to approach the study to patients (Table 1d).  Surgeons found 
most patients were willing to participate in the study, unless patients did not have time 
before or after the study to participate because of personal commitments.  The study took 
a maximum of 40 minutes to complete for each participant.  For a full study to be 
completed, the sample size per group will range between 16 to 120 patients or between 
32 to 240 participants in total depending on the outcome measure (Table 4).  In regarding 
recruitment, recruitment was slow in the spring and summer months between May to 
August.  Only one patient came in during that time period.  During the spring and 
summer months were when most patients refused to participate because they had other 
time commitments after their medical appointment.   
In terms of methodological concerns, equipment and protocol was straight forward to 
follow and complete.  Training took 2 weeks for the evaluator at the laboratory to become 
familiarized with using the five measurement outcomes.  The evaluator required the most 
time learning how to operate the TIVI system properly, as it was a new addition to the 
existing laboratory.  Learning to capture photos and analyze the data took 10 working 
days.  Two experienced research assistants trained the evaluator to use the PSSD for two 
30 minute sessions.   
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Objective 2:  Impact of Texting on Touch Threshold, Superficial Red Blood Cell 
Concentration, and Symptoms.  Prior to texting, patients demonstrated significantly 
higher touch threshold (4.04g/mm
2
 versus 2.62 g/mm
2
) (p = 0.014) (Table 2 and Figure 
3) and higher ratings on symptoms (all p<0.05)(See Table 2 and Figures 4,5, and 6).  
Patients had on average 3 points higher for pain and fatigue, and 4 points higher for 
numbness than controls.  There were no significant differences in superficial red blood 
cell concentration between groups at baseline; although patient scores were on average 15 
A.U. higher, but was not statistically significant (736 A.U. versus 682 A.U.) (p = 0.29).   
After texting, touch threshold increased significantly for patients, and touch threshold 
values did not return to baseline levels at 10 minutes after texting (Table 2 and Figure 3).  
There were gradual increases in symptoms of pain, and numbness after texting for the 
patient group, but the increases were not significantly different from baseline.  Fatigue 
increased significantly only immediately after texting Table 2 and Figure 6).  All 
outcome measures for the control group did not change significantly from texting.  
3.8.1.1 Description of Outcome Measures at Baseline, 
Immediately after Texting, 2 minutes, 5 minutes, and 10 
minutes after Texting   
Superficial Red Blood Cell Concentration.  At baseline before texting, patients 
had 8% more superficial red blood cell concentration compared to controls 
(736.08 A.U. versus 682.20 A.U. for patients and controls respectively), but was 
not significantly higher than baseline (p=0.29).  After texting, patients had a 
decrease of 0.3% from baseline following texting, and controls had a decrease of 
2.2% from baseline superficial red blood concentration immediately following 
texting.   No significant changes were found over time (p=1.00).  
Red blood cell concentration remained relatively constant throughout the study 
(p=1.00), and patients had higher red blood cell concentration compared to 
controls, but was not significantly higher (p = 1.00) (Figure 2).  For patients, red 
blood cell concentration decreased from 736.08 at baseline to 733.88 immediately 
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after texting (0.3% decrease from baseline).  Patients had a decrease immediately 
after texting from 733.88 A.U. to 704.49 A.U. at 2 minutes (4.3% decrease from 
baseline), 751.45 A.U. at 5 minutes (2% increase from baseline), and 705.54 A.U. 
at 10 minutes after texting (4% decrease from baseline).  Controls had a decrease 
immediately after texting from 682.2 A.U. to 667 A.U. (2% decrease from 
baseline).  The red blood cell concentration for controls decreased from baseline 
at 682.20 A.U. to 667 A.U. at 2 minutes,(0.7% decrease from baseline), then 
decreased to 675.16 A.U. at 5 minutes (1% decrease from baseline), and then 
decreased to 644 A.U. at 10minutes after texting (5.6% of baseline).   
Touch Threshold.  Patients had 53% higher touch threshold values compared to 
controls at baseline before texting (4.04g/mm
2
 versus 2.62g/mm
2
 for patients and 
controls respectively).  Patients’ touch threshold significantly increased by 66% 
from baseline immediately after texting (4.04 to 6.71g/mm
2
) (p = 0.008), whereas 
the touch threshold for controls increased by 14% (2.62g/mm
2
 to 3.00g/mm
2
) 
(p=1.00).     
After texting, touch threshold values for patients remained higher than baseline, 
and did not return towards baseline at 2, 5, or 10 minutes after texting.  After 
texting, touch threshold for patients decreased from 6.71g/mm
2
 to 5.51g/mm
2
 at 2 
minutes (136% of baseline value)(p=0.09), increased to 6.19 g/mm
2
 at 5 minutes 
(153% of baseline value)(p=0.02), and decreased to 5.51g/mm
2
 at 10 minutes 
after texting (136% of the baseline magnitude)(p=0.035)(Figure 2). The touch 
threshold value at 5 minutes and 10 minutes after texting were significantly higher 
than the baseline value, but not the touch threshold value at 2 minutes after 
texting.  After texting, the control group experienced a decrease in touch threshold 
from 3.00g/mm
2
 to 2.27g/mm
2
 at 2 minutes (87% of baseline value), then 
increased to 2.48 g/mm
2
 at 5 minutes (95% of baseline value), and then increased 
to 2.45g/mm
2
 at 10 minutes after texting (94% of baseline value).  No significant 
differences were found between baseline and follow up values for the control 
group (p = 1.00). 
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Pain.  At baseline before texting, patients had pain ratings 3 points higher than 
controls (2.73 versus 0.07 points for patients and controls respectively) at baseline 
(Table 2). Patients experienced significantly more pain than controls (p<0.05).  
After texting, patients experienced an increase of 1 point more pain (2.73 and 3.87 
points before and after texting respectively), although not significantly higher 
than baseline (p=0.152), whereas the controls did not experience substantial 
change in pain ratings after texting (0.07 to 0.13 points before and after texting 
respectively) (p=1.00).  
After texting, pain ratings decreased towards scores at baseline for patients and 
pain scores were not significantly different from baseline (p=0.15 -1.00).  Pain 
ratings remained relatively unchanged for controls (p=1.00) (Table 2 and Figure 
4).  Differences on pain ratings were +0.07, -0.2, and +0.2 point between baseline 
and follow up scores at 2 minutes, 5 minutes, and 10 minutes respectively after 
texting for patients.  The differences in pain ratings for controls between baseline 
and follow up points at 2, 5, and 10 minutes after texting were 0, +0.13, and -0.07 
point respectively.  Pain scores after texting did not differ significantly from the 
baseline pain score (p = 1.00). 
 
Numbness.  Patients had numbness ratings which were on average 4 points 
higher than controls at rest, which was significantly higher (p<0.05).  Patients 
experienced an increase of 0.6 point in numbness after texting, whereas controls 
had increase of 0.21 point in numbness ratings.  Neither group experienced a 
significant change in numbness after texting (p=1.00). 
After texting, rating score for numbness decreased towards baseline for the patient 
group.  Differences on ratings for numbness were +0.27, -0.33, and 0 point 
between baseline and follow up scores at 2 minutes, 5 minutes, and 10 minutes 
respectively after texting for patients.  The differences in ratings for numbness 
between baseline and follow up points at 2, 5, and 10 minutes after texting were 
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+0.07, +0.14, and 0 point respectively for controls, which were not significantly 
different from the baseline value (p=1.00) (Table 2 and Figure 5).  
Fatigue.  Patients had fatigue ratings which was 3 points higher than controls at 
baseline.  Patients had fatigue ratings 2 points higher than controls (p<0.05).  
Patients experienced a significant increase of 2 points in fatigue rating 
immediately after texting (p=0.016), whereas controls had a 1 point increase in 
fatigue immediately after texting, although the change was not significant from 
baseline (p=0.33).  
After fatigue increased from texting, fatigue ratings decreased towards scores at 
baseline for patients and controls (Table 2 and Figure 6).  Differences on ratings 
for fatigue were +0.4, -0.06, and +0.14 point between baseline and follow up 
scores at 2 minutes, 5 minutes, and 10 minutes respectively after texting for 
patients.  No significant differences were found between baseline and follow up 
points for patients (p=1.00).  The differences in ratings for fatigue between 
baseline and follow up points at 2, 5, and 10 minutes after texting were +0.6, 
+0.33, and +0.13 point respectively.  No significant differences were found 
between baseline and follow up points for controls (p=1.00).   
Objective 3:  Performance differences between Patients and Controls.  When 
experience was controlled for in texting performance, patients with CTS texted 
fewer characters [F (1,27) = 19.81 (p<0.05), ƞ 2 = 0.42] (Table 3) and had a 
slower texting speed than controls [F(1,27) = 22.63 (p<0.05), ƞ 2 = 0.46)] (Table 
3).  No difference was found in the duration of time patients and controls were 
able to text (F(1,27) = 2.50 (p=0.13), ƞ 2  = 0.085) (Table 3).  All 15 controls 
performed 15 minutes of texting, but only 12 out of 15 patients completed the full 
15 minutes.   
 
 
70 
 
Table 3.1a  1 Sample Characteristics  
Characteristics Patients (mean ± SD) 
(median) 
Controls (mean ± SD) (median) 
Age(years) 48 years old ± 11 years   
(50) 
46 years old ± 11 years  
(49) 
Men:  Women  7:8 7:8 
Symptom Duration 
(weeks) (±SD) 
266 ± 425.75 
(112) 
Does not apply 
right: left hand ratio 10:5 10:5 
Ratio of 
participants familiar 
with texting on 
QWERTY keypad: 
Not familiar with 
texting on 
QWERTY keypad 
10:5 10:5 
SSS 3.04 1 
SD = Standard Deviation.  SSS = Symptom Severity Scale  
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Table 3.1b 1: Reasons for Lack of Eligibility Based on Exclusion Criteria 
Exclusion Criteria Description of 
Exclusion Criteria   
Number of 
Patients 
Excluded from 
Study 
Percentage of Total 
Potential Patient 
Participants 
Diabetes Diabetes can impair 
sensation in the hand.  
Did not discriminate for 
patients who are insulin 
dependent.  Patients 
who are not dependent 
on insulin may not have 
impairments to 
sensation. 
7 9.9% 
Too old (>65 years 
old) 
N/A 16 23% 
Injury to Upper 
Extremity (Co-
morbidity) 
Trigger finger, swelling, 
elbow injury, and 
osteoarthritis 
10  14% 
Surgery has been 
done previously 
Surgery was performed 
previously by surgeons 
at this site.  Certain 
health conditions may 
be the cause of 
patients to come in for 
second surgery.  
2  2.8% 
Heart Condition Patients had abnormal 2  2.8% 
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heart beat which may 
influence TIVI values. 
CTS was not 
confirmed by 
surgeon on site 
Patients were 
suggested to have CTS 
by their family 
physician 
2 2.8% 
Total   39 55%* 
*value has small degree of rounding error  
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Table 3.1c  1:  Reasons for Refusal to Participate 
Reason for Not 
Participating in Study 
Number of Participants  Percentage of Total 
Potential Patient 
Participants 
Not Interested 5 7.0% 
Language barrier (i.e. did 
not understand English) 
1 1.4% 
Withdrew from study (to 
attend appointment with 
surgeon) 
1 1.4% 
Total 7 10%* 
*value has small degree of rounding error  
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Table 3.1d 1 Reasons for Not Approaching Potential Participants 
Reason for Not 
Participating in Study 
Number of Participants  Percentage of Total 
Potential Patient 
Participants 
Timing (i.e. secretaries 
felt it was too early in the 
morning for patients and 
commute to hospital) 
2 2.8% 
Missed opportunity to 
recruit patient (i.e. illness) 
5 7.0% 
Patient Missed 
Appointment with 
Surgeon 
3 4.2% 
Total 10 14%* 
*value has small degree of rounding error
  
Tool Group  Baseline 
 
Immediately after 
Texting  
2 min after Texting  5 min after  
Texting  
10 min after  
Texting 
 
PSSD Patient Mean (SD) 4.04  
(3.36) 
6.71  
(5.94) 
5.51 (3.51) 6.19  
(5.58) 
5.51  
(3.91) 
Median  3.00 4.70 5.20 5.20 4.70 
 Control Mean (SD) 2.62  
(1.84) 
3.00  
(2.10) 
2.27  
(1.60) 
2.48  
(1.66) 
2.45 
(1.64) 
Median  1.80 2.00 1.70 1.70 1.90 
TIVI Patient Mean (SD) 736.08 (154.43) 733.88  
(149.90) 
704.49 (129.79) 751.45  
(133.00) 
705.54  
(104.69) 
Median 714.82 730.00 690.23 778.93 677.94 
 Control Mean (SD) 682.20 (185.54) 667.00  
(16.20) 
683.00 (180.00) 675.16 (182.48) 644.00  
(147.71) 
Median 664.04 662.50 648.33 649.56 646.64 
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Descriptive Data of Outcome Measures for Measuring Effects of Texting 
  
Tool Group  Baseline 
 
Immediately after 
Texting  
2 min after Texting  5 min after  
Texting  
10 min after  
Texting 
 
Pain Patient Mean (SD) 2.73 (2.01) 3.87 
(2.77) 
2.80  
(2.83) 
2.53 
 (3.00) 
2.93 
(2.88) 
Median 3.00 3.00 2.00 1.00 2.00 
 Control Mean (SD) 0.07  
(0.26) 
0.13  
(0.35) 
0.07  
(0.26) 
0.20 
 (0.56) 
0.00 
Median  0.00 0.00 0.00 0.00 0.00 
Fatigue Patient Mean (SD) 2.93  
(2.31) 
4.80   
(2.98) 
3.33  
(2.91) 
2.87  
(2.85) 
3.07 
 (2.60) 
Median 3.00 5.00 2.00 2.00 2.00 
 Control Mean (SD) 0.07  
(0.26) 
1.27 
(1.44) 
0.67  
(1.11) 
0.40  
(0.63) 
0.20  
(0.41) 
Median 0.00 1.00 0.00 0.00 0.00 
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Tool Group  Baseline 
 
Immediately after 
Texting  
2 min after Texting  5 min after  
Texting  
10 min after  
Texting 
 
Numb 
-ness 
Patient Mean (SD) 4.00  
(3.02)  
4.60 
 (3.22)  
4.27  
(3.10) 
3.67  
(3.72) 
4.00  
(2.95) 
Median 3.02 3.22 3.10 3.18 2.95 
 Control Mean 0.00 0.21  
(0.77) 
0.07  
(0.27) 
0.14  
(0.36) 
0.00 
Median  0.00 0.00 0.00 0.00 0.00 
 
 
Table 3.2:  Descriptive Data of Outcome Measures for Measuring Effects of Texting  
SD = standard deviation.  Min = minutes 
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Table 3.3:  Descriptive Data of Texting Performance 
** = significantly higher  
SD = Standard Deviation  
Characteristic of Texting 
Performance 
Patients Controls 
Number of Characters 
Texted (mean)(SD) 
631 (246) 993 (209)** 
Duration of Texting 
(seconds) (SD) 
809.87 900 
Average Texting Speed 
(characters/second) (SD) 
0.76 (0.19) 1.10(0.23) ** 
% Completed Texting Task 80% 100% 
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Figure 3.1:  Flow Chart Detailing the Recruitment of Patient Participants 
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Figure 3.2:  Changes in Red Blood Cell Concentration in Patients over Time 
TIVI = Tissue Viability Imaging   
Min post = minutes post texting  
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Figure 3.3:  Changes in PSSD over Time for Patients and Controls 
PSSD = Pressure Specified Sensory Device  
Min post = minutes after texting 
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Figure 3.4:  Changes over time with Pain  
Min post = minutes after texting 
** 
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Figure 3.5 Changes over time with Numbness  
Min post = minutes after texting 
** 
** 
** ** ** 
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Figure 3.6:  Change over Time with Fatigue 
Min post = minutes after texting 
** 
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Measurement 
outcome  
Sample Size 
Required per 
group 
Patients to be 
Screened Based 
on Accrual Rate 
of 21%  
Total Number of 
Participants 
PSSD 120 571 240 
TIVI 23 110 46 
Pain NRS 16 76 32 
Fatigue NRS 36 171 72 
Numbness NRS 36 171 72 
Table 3.4:  Comparison of Sample Sizes Required for a Full Study 
PSSD = Pressure Specified Sensory Device, TIVI = Tissue Viability Imager, NRS = 
Numeric Rating Scale
  
 Pilot Full Study  Rational for Changes to 
Pilot Study  
Study Design Test Retest study Test Retest study  Appropriate for methodology 
Exclusion Criteria 
 Received previous surgery for CTS 
 Diabetes  
 Younger than 18 years old or older 
than 65 years old  
 Recent or current injury to the upper 
extremity, including neck – muscle, 
bone, or nerve injury (within the past 
year)  
 Osteoarthritis  
 Heart Condition 
 Ongoing cancer 
 CTS with ongoing pregnancy   
 Vascular problems with the hands or 
arms (i.e. Raynaud’s Syndrome)  
 
 Received previous surgery for CTS 
 Diabetes without altered sensation 
from diabetes. 
 Younger than 18 years old and under 
65 years old  
 Injury to the hand or wrist (i.e. 
fracture, osteoarthiritis, amputation) 
(within the past year)  
 CTS with ongoing pregnancy   
 Vascular problems with the hands or 
arms (i.e. Raynaud’s Syndrome)  
 
The exclusion criteria on recent injury 
eliminated 14% potential candidates 
from the study. It was the 2nd top 
reason patients were excluded and too 
conservative.  Patient with recent minor 
injuries should be allowed to participate.   
 
Although some patients have diabetes, 
they may not have impaired sensation. 
Diabetics who do not require insulin 
injection should not be excluded from 
this study.    
 
Aging is known to be factor to result in 
peripheral nerve degeneration and 
touch threshold increases with age. 
34, 35
  
36-38
 
Sample Size 15 per group  Depends on outcome measure (Table 4) http://stat.ubc.ca/~rollin/stats/ssiz
e/n2.html 28 
Study Intervention  Texting on cell phone for 15 minutes from 
questionnaire 
Texting on cell phone for 15 minutes from 
questionnaire.   
Cell phone models and type should be 
chosen carefully.   
Some participants were more familiar 
with their own cell phone rather than the 
one provided.  Index finger could also 
be used for texting.   
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Pilot Full Study  Rational for Changes to 
Pilot Study  
Pilot 
Setting Research laboratory at tertiary health 
care setting specializing in upper 
extremity  
Research laboratory at tertiary health 
care setting specializing in upper 
extremity  
Environment is suitable for recruiting 
patients with CTS. 
Measurement 
Outcomes 
 TIVI 
 PSSD  
 Numeric Rating Scale for Pain 
 Numeric Rating Scale for Numbness 
 Numeric Rating Scale for Fatigue 
 TIVI 
 PSSD  
 Numeric Rating Scale for Pain 
 Numeric Rating Scale for Numbness 
 Numeric Rating Scale for Fatigue 
All tools were straight forward to 
operate.  Testing took maximum of 40 
minutes to complete. 
Table 3.5:  Comparison of Exclusion Criteria, Sample Size, and Outcome Measures for Pilot and Full Study 
TIVI = Tissue Viability Imaging, PSSD = Pressure Specified Sensory Device 
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3.9 Discussion  
 
In this pilot study, we examined the differences between and within a group of patients 
with CTS and a group of age and gender matched controls after completing a texting task. This 
study found that patients with CTS experienced more symptoms and had more impairment to 
sensation compared to age and gender matched controls at all time points.  In terms of texting 
performance, patients also performed worse than controls.   
Study Feasibility: 
This pilot study can be expanded into a full study with some changes to the exclusion criteria.  
Our primary focus for this study was to examine the feasibility of recruiting patients for this 
study.  We were able to determine a sample size that was under 300 subjects, have an exclusion 
criteria rate less than 60%, participation rate greater than 20%, and have a withdrawal rate of less 
than 20%.  Recruitment of patient participants by surgeons seems to be the most optimal method, 
as most patients were willing to participate.  Our exclusion criteria for excluding any potential 
patient with other recent hand injuries were too conservative at times.  We felt that hand injuries 
occur commonly and we were limiting our recruitment to patients with CTS and no other 
injuries.  For example, a patient who has a minor bruise or cut on the palms could be recruited.  
In addition, diabetics who are not insulin dependent could be included in this study.  Those with 
diabetes were originally excluded from this study was because they were assumed to all suffer 
from neuropathy and have altered sensation caused by diabetes.  However, not all diabetics 
suffer from peripheral neuropathy 
39
 and patients with diabetes without neuropathy could be 
recruited for the study.  These considerations may help increase the recruitment of patient 
participants by changing the exclusion criteria to be more liberal.  The age range was 
appropriate, as we captured the age range of working adults and the ages when most patients 
suffer from CTS.  Aging has been associated to age related changes to sensory threshold 
34, 35
 
36-
38
 and it seemed appropriate to exclude adults over 65 years of age.   
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Recruiting controls was not an issue for this pilot study, as many healthy hospital workers 
were available for the study, and were willing to participate.  Candidates who would qualify for 
the control group would be considered anyone without CTS and any other injury to the upper 
extremity.  A total of 20 controls were recruited for the study, but only 15 controls were 
analyzed.  During the recruitment process of healthy controls, no records were made to document 
how many hospital staff were asked to participate in the study.  Controls were invited to be part 
of the study by word of mouth and announcements made at the staff meetings at the hand therapy 
and physiotherapy department of the tertiary center.  Nineteen controls were recruited by word of 
mouth and would probably be the best way to approach controls for a larger study.  As for 
posters posted in the hospital hallways, only one control was recruited.  Overall, the best strategy 
for recruiting controls seems to be by word of mouth and announcements.   
As hypothesized, patients experienced more classical symptoms of CTS compared to 
controls at baseline in this study.  However, pain and numbness were not significantly different 
after texting for the patient group, but scores did increase gradually during texting and decreased 
after texting.  Pain and numbness may have increased from wrist posture, combined with 
constant gliding of the tendons in the carpal tunnel with repetitive forces, which could increase 
the pressure exerted against the median nerve, and associated structures, aggravating symptoms.  
Kier et al 
9
 did a biomechanical study examining the changes in carpal tunnel pressure from 
changes in wrist posture (extension versus flexion and radial versus ulnar deviation) and with 
finger posture (0, 45, or 90 degrees flexion).  The study found that carpal tunnel pressure 
increased the most with wrist extension with straight fingers.  Radial and ulnar deviations also 
increased carpal tunnel pressures. 
9
 This study suggested that the increased pressure could 
aggravate symptoms in patients with CTS based on hand postures. 
9
In addition, since the texting 
activity required force application on the distal pulp of the thumbs, it is possible the force could 
also aggravate the symptoms during texting.  Rempel et al 
40
 performed a biomechanical study, 
and found that the application of a force at the tip of the digits increased carpal tunnel pressure.  
In our study, posture and forces at the pulps of the thumbs were not measured, but could be 
performed in future studies to track changes to these variables throughout texting.  Most patients 
in our study needed to shake their injured hand(s), or have the forearm point downwards with the 
wrist in neutral position to minimize the numbness the patient participants were experiencing 
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after texting.  The neutral wrist posture and having the forearm pointing downwards may have 
helped to alleviate symptoms by decreasing carpal tunnel pressure.   
However, it is important to note that the gradual increase in pain and numbness lacked 
potential power to conclude results on the effects of cell phone texting within groups.  The small 
sample size of 15 participants is not large enough to say this did not happen by chance.  The 
sample size calculation for each measurement outcome demonstrated that the sample size of 15 
participants per group was too small (Table 4).  A future study should be performed to determine 
the sample size required for more conclusive results for within group comparisons.   
Patients also demonstrated a significant increase in touch threshold after texting, and also 
at 5 and 10 minutes after texting (Figure 2).  It has been established in previous literature that 
patients with CTS have higher touch threshold levels than healthy individuals.
10, 11
  Compression 
of the median nerve may decrease the nerve conduction velocity and magnitude of signals from 
the Merkel disks and Pacinian corpuscles, resulting in a higher touch threshold in the thumbs.  
Thus, more pressure was required for patients to detect touch stimuli.  In a study by Gelberman 
et al, 
41
 the researchers tested the influence of different carpal tunnel pressures on touch 
threshold, nerve conduction tests, and functional tests in 12 healthy individuals.  The participants 
had their carpal tunnel pressure increased with a catheter, and outcome measures were taken at 
baseline and after carpal tunnel pressure were increased. 
41
 They found that as carpal tunnel 
pressure increased, touch threshold values with the Semmes Weinstein monofilament also 
increase. 
41
 There was an increase in self-reported parathesia with increased carpal tunnel 
pressure. 
41
 This may suggest that texting on a cell phone increases carpal tunnel pressures for 
patients with CTS, and results in increased touch threshold values.  Even after the testing, PSSD 
scores for patients did not return back to levels at baseline for patients.  However, the PSSD may 
have high measurement error, as the confidence intervals are fairly wide.  The PSSD might be a 
very sensitive tool for detecting abnormal sensation, as it has high sensitivity for detecting 
diseases, such as neuropathies caused by diabetes, 
42
 and CTS.  
43
  Its sensitive nature might be 
demonstrated in its ability to measure change after texting activity.   
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Both controls and patients experienced fatigue after texting. A study that supports our 
findings on fatigue examined the occurrence of muscle fatigue in the forearms of computer users 
after prolonged typing.  Lin et al 
44
 used electromyography to quantify forearm muscles in 30 
female typists who typed for 2 hours continuously.  They found that 74% of the measured 
forearm muscles manifested fatigue, and that extensor digitorum communis presented more 
fatigue than forearm flexor muscles.  
44
  The sensation of fatigue may have resulted from lactic 
acid accumulation in the thenar and forearm muscles, as a result of contraction of muscles in the 
hand during texting activity.  Fatigue was present in the computer typing tasks requiring long 
term dynamic contractions with forces less than 10% of maximum voluntary contractions. 
44
 
Future research should be done to verify the mechanisms behind fatigue in low level hand 
activity and in patient populations requiring cell phone texting as part of their daily activity.   
Red blood cell concentration values from the TIVI remained relatively stable throughout the 
study for both patients and controls.  Patients had higher red blood cell concentration than the 
controls throughout the study.  This finding is similar to results a study by Gelberman et al, 
41
 
where arterial and venous blood flow did not change by increases in carpal tunnel pressure 
among healthy individuals. 
41
 Previous studies have found that patients with CTS have slower 
blood flow compared to controls. 
45, 46
 The differences in findings in our study and previous 
studies may be due to the penetration ability of the light used in quantifying blood flow between 
different methods of examining blood flow.  Other studies had used Laser Doppler Systems, 
which examines deep into tissue and provide a more precise measurement of blood flow. The 
TIVI software only measures red blood cell concentration on the superficial skin level, so deeper 
blood flow was not measured. This study is one of the initial studies on measuring superficial 
blood flow in patients with CTS.  We suggest there should be more studies on this topic in the 
future.   
As expected, patients typed fewer characters and had slower texting speed.  Patients may 
have performed worse than controls because the texting activity may have aggravated their 
symptoms, so the patients texted fewer characters and texted slower to reduce the symptoms. We 
had 3 patients who stopped texting early before the 15 minute mark because the numbness was 
too bothersome, and interfered with their ability to text.  This was not the same found from 
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Guftasson et al, where young adults were asked to text on a cell phone and had 
electromyography and performance measurements (i.e. texting duration) taken. 
5
 In a subgroup 
analysis of the group with hand/arm symptoms, they required less time to perform the texting 
task compared to individuals without symptoms. 
5
 Despite this difference, our study had a 
specific patient population which was clinically diagnosed and did not have comorbidities.  
This study has a number of strengths and novel findings.  It evaluated patients and controls 
using self-reported measures which would accurately measure their symptoms which they feel 
and how these symptoms changed over time.  The tools used in this study are commonly used 
within clinical and ergonomic settings and these tools would be highly accessible.  This study 
also compared patients with CTS to an age and gender matched control group.   Our study had 
patients between the age ranges of 29 to 65 years of age.  Women between 35 to 44 years of age 
have the highest rates of CTS claims from work, and for men between ages 35 to 54 years of age 
in Canada. 
47
 Previous studies examining texting have primarily focused on younger adults in 
university settings, 
6, 48
 
49
 , but did not report the ages of the participants.  Additionally, 
university students would not accurately represent the general working adult population between 
35 to 65 years old.  The texting activity was designed to simulate an environment outside of a 
laboratory.  The task allowed participants to choose a posture that was comfortable to them, to 
accommodate for variability in hand, and trunk postures while in seated position.  The 
questionnaire used for the texting intervention also contained open ended questions, which 
allowed for variability in responses according to the participants’ preferences.   
Our study also had some potential weaknesses.  We recruited a small sample size of patient 
participants and controls.  A larger sample of patient participants would be required to have 
sufficient power in multivariate calculations, and decrease the probability of potential type II 
error to allow for more conclusive results on between and within group differences.  In addition, 
we used only one model of cell phone for our study.  The nature of the texting activity in this 
study was restricted to texting with only the thumbs.  Performance may vary depending on the 
specific digits used for texting and on the model of cell phone used for texting.  We recommend 
future studies to use different models of cell phones.    
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3.10 Conclusion and Implications: 
This pilot study provides valuable information on how cell phone texting affect patients 
with CTS. The study found that patients experienced more symptoms than controls after 
texting.  Patients with CTS also performed worse than age and gender controls in texting.  
However, the results were under powered to make conclusive statements.  This pilot 
study also provides important information for future studies involving patients with CTS 
and cell phone texting.   
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4 Overview of this Thesis  
The overall theme in this thesis was to explore the properties and applications for sensory 
tools among patients with CTS.  We wanted to explore how certain tools responded to 
orthotic intervention and after common hand activities.  The specific focus of this thesis 
was to evaluate the psychometric properties (clinical important difference, construct 
validity, and responsiveness) of sensory threshold tools after orthotic treatment in CTS 
and to determine the effects of cell phone texting on blood flow and sensation in CTS. 
The details of the findings of this thesis are: 
In the first study, we tested two sensory tools (one for vibration threshold and one for 
touch threshold).  We determined the clinically important difference of the tool for 
measuring touch threshold and the outcome measure for rating symptom severity.  We 
found that the tool for measuring vibration threshold demonstrated greater construct 
validity to measures of hand function and was more responsive compared to touch 
threshold.   
In the second study, we determined the feasibility of conducting a large scale study in a 
hospital setting and the adverse effects of cell phone texting in CTS in comparison with 
healthy controls. 
4.1 What is Already Known on This Topic 
Sensory testing is a common method of verifying a diagnosis for neuropathy and for the 
evaluation of neuropathy.  The CID of the SSS has been determined for after surgery, 
1
 
and steroid injection. 
2
 Sensory threshold tools have demonstrated substantial change 
between preoperative measures and after surgery. 
3
   Sensory tools have also been found 
to be reliable. 
4-6
 However, limited research has been done examining the construct 
validity of sensory tools to functional measures, and the responsiveness of sensory tools.   
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Texting on a cell phone has been shown to increase muscle activity in the musculature of 
the hand in patients with upper extremity injury. 
7
 However, limited research has 
examined the short term and long term effect of cell phone texting in patients with CTS.   
4.2 What This Thesis Adds to Our Knowledge Base 
The first study found the CID to discriminate patients who responded to orthotic 
intervention for the PSSD and the SSS.  The CID for the PSSD and the SSS were 
0.15g/mm
2
 and 0.50 respectively.  The Vibrometer is a better overall representation of 
functional measures for the hand and is more responsive after orthotic intervention.  
The second study determined that the recruitment of patient subjects was feasible to 
expand into a larger study to compare the effects of cell phone texting in patients with 
CTS with age-gender matched controls.  Our study had a recruitment rate of 73%. In 
order to complete a full study, we would need to have 182 participants (or 92 participants 
per group) to complete a full study [based on an 80% power (α= 0.05, β= 0.20), and in 
order to detect a 20% difference between-groups.] 
4.3 Implications 
Sensory evaluation is a determining component in a peripheral nerve entrapment, 
especially in CTS.  This thesis has provided evidence based research for two sensory 
tools during the rehabilitation process to guide clinical decisions on interpreting sensory 
measures.  In addition, this thesis provides preliminary findings on the impact of specific 
activities on patient symptoms during the recovery period. This thesis helps provide 
insight for clinicians to answer the question, “How can I tell if the sensory ability and 
symptoms in my patients are improving or worsening from a specific intervention or 
activity?”  
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4.4 Limitations 
This thesis did have some limitations on the whole.  We were unable to establish a cut 
point for the Vibrometer for discriminating patients after orthotic intervention.  All 
subjects who were tested with the Vibrometer had achieved an important improvement on 
the SSS.  We also had inconclusive findings on the impact of texting on superficial blood 
cell concentration, sensory threshold and symptoms because of small sample size of n=15 
in pilot study.  We were unable to make conclusive statements about the impact of 
texting, since it was under powered.   
4.5 Future Research Directions and Recommendations 
 Recommendations for future psychometric studies: 
 Future studies should focus on examining the clinically important change on 
commonly used tools in clinics.   
 Clinical tools should have their psychometric properties validated to provide 
important information for clinicians, including reliability, validity, and the ability 
of a tool to measure change.  
8
  The property of construct validity, responsiveness, 
and clinically important change help to inform a clinicians’ decision when 
treating patients with CTS.   
 Future studies should also examine the decision making process of how clinicians 
use findings from sensory tools to inform their practice for treating CTS.   
4.6 Recommendations and Future Research Directions for Pilot Studies:   
 A full study should be completed with 182 participants to evaluate the long term 
effects of texting in patients with CTS and in healthy controls.    
 Exclusion criteria for recruiting participants should be more specific to clearly 
identify eligible patients for the future full study. 
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 Different cell phone models should be tested to capture variability in texting 
performances  
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Appendix A 2 – Screen Tool for Chapter 3 
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Screening Tool for CTS Study 
Name: _____________________________ 
Date: _______________________________ 
This form will be completed by the potential participant to screen participants for the 
study by verbal response to each question the investigator will read to him or her.  The 
investigator will fill in the form by putting an “x” in the boxes indicating Yes or No.  If 
the participant is uncertain, he or she will be asked to answer to the best of their ability.     
Question Yes No  
1. Are you confirmed by a health provider from St. Joseph’s hospital to have 
Carpal Tunnel Syndrome?    
2. Are you between the ages of 18-65 years old 
  
3. Have you received any treatment offered by any hospital for the symptoms 
for carpal tunnel syndrome?   
4. Have you had a recent injury to your neck, shoulder, elbow, wrist, or hand 
within the past year – muscle, bone, nerve injury, osteoarthritis (as of 
January 2011)  
  
5. Do you have a heart condition? 
  
6. Are you a  diabetic  
  
7. Are you pregnant? 
  
8. Do you have cancer or a tumour? 
  
9.  Do you have any vascular problems in your hands or arms?   
  
*If YES to 1 and NO to 3-9, then put into as PATIENT  
*If No to 1, 3-9, then put into as CONTROL  
*If yes to one of questions 3-9 regardless, then exclude from study 
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If eligible as patient: 
Thank you for your time. You are eligible for this study.  
If not eligible as patient: 
Thank you for your time. You are not eligible for this study. Is it okay though to 
keep your name on our database so that we can contact you for other studies? 
If eligible as control: 
Thank you for your time. You are eligible for this study.  
If not eligible as control: 
Thank you for your time. You are not eligible for this study. Is it okay though to 
keep your name on our database so that we can contact you for other studies? 
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Appendix A 3 – Numeric Rating Scale for Pain, Fatigue, and Numbness 
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Subject Code: _______________    
 Stage:______________ 
 
Numeric Rating Scale for Pain, Fatigue, and Numbness in the 
Hand 
At this moment:      
Please rate the pain in each hand from 0-10.   0 being no pain.  10 
being the worst pain experienced.  Circle the corresponding 
number and label it with “R” for right hand or “L” for left hand.   
 
(NONE) 0 1 2 3 4 5 6 7 8 9
 10  (WORST) 
Please rate the fatigue in your hand from 0-10.  0 being no fatigue 
in your hand.  10 being “too fatigued to continue.” Circle the 
corresponding number and label it with “R” for right hand or “L” 
for left hand.   
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(NONE) 0 1 2 3 4 5 6 7 8 9
 10 (WORST) 
 
Please rate the Numbness or Tingling experienced in your hand 
from 0-10.  0 being no numbness or tingling.  10 being unable to 
feel anything.  Circle the corresponding number and label it with 
“R” for right hand or “L” for left hand.   
 
(NONE) 0 1 2 3 4 5 6 7 8 9
 10  (WORST) 
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Appendix A 4 – Script 
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Standardized Script (Dec 27, 2011). 
Please respond to each of the questions with the cell 
phone by texting in your response using only your 
thumbs.  After each response is entered, please enter 
a period and a space before entering in the next 
response.   
This script will have repeated questions – just 
continue answering them.  If you make an error, 
please correct the mistake with the delete button as in 
the practice session.    
Once time is up, please send the entire text to 
derek.kmcheung@gmail.com .   
1. How did you hear about this study?  
 
2. Where do you plan to go after this study? 
 
3. Where is your favourite place for vacation?  
 
4. How many times have you been there? 
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5. What would you recommend others to see if they went 
to visit? 
 
 
6. When is the next time you would like to visit that 
place? 
 
 
7. If you were given a billion dollars, what would you do 
with it? 
 
8. If you could give a billion dollars to anyone, who 
would that be? 
 
9. What is your favourite hobby?   
 
10. Would you do it for a living?   
 
11. If yes, why would you do it for a living?  If no, 
why not? 
 
12. What does TTYL mean?   
 
13. What does LOL mean? 
112 
 
 
 
14. What does TGIF mean? 
 
15. What does FYI mean? 
 
16. What does XOXO mean? 
 
17. What does BRB mean?    
 
18. Do you find this winter very cold?   
 
19. Are you a tea or coffee drinker? 
 
20. Have you had tea or coffee today? 
 
21. How did you hear about this study?  
 
22. Where do you plan to go after this study? 
 
23. Where is your favourite place for vacation?  
 
24. How many times have you been there? 
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25. What would you recommend others to see if they 
went to visit? 
 
 
26. When is the next time you would like to visit that 
place? 
 
 
27. If you were given a billion dollars, what would 
you do with it? 
 
28. If you could give a billion dollars to anyone, who 
would that be? 
 
29. What is your favourite hobby?   
 
30. Would you do it for a living?   
 
31. If yes, why would you do it for a living?  If no, 
why not? 
 
32. What does TTYL mean?   
 
33. What does LOL mean? 
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34. What does TGIF mean? 
 
35. What does FYI mean? 
 
36. What does XOXO mean? 
 
37. What does BRB mean?    
 
38. Do you find this winter very cold?   
 
39. Are you a tea or coffee drinker? 
 
40. Have you had tea or coffee today? 
 
41. How did you hear about this study?  
 
42. Where do you plan to go after this study? 
 
43. Where is your favourite place for vacation?  
 
44. How many times have you been there? 
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45. What would you recommend others to see if they 
went to visit? 
 
 
46. When is the next time you would like to visit that 
place? 
 
 
47. If you were given a billion dollars, what would 
you do with it? 
 
48. If you could give a billion dollars to anyone, who 
would that be? 
 
49. What is your favourite hobby?   
 
50. Would you do it for a living?   
 
51. If yes, why would you do it for a living?  If no, 
why not? 
 
52. What does TTYL mean?   
 
53. What does LOL mean? 
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54. What does TGIF mean? 
 
55. What does FYI mean? 
 
56. What does XOXO mean? 
 
57. What does BRB mean?    
 
58. Do you find this winter very cold?   
 
59. Are you a tea or coffee drinker? 
 
60. Have you had tea or coffee today? 
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Appendix A 5 - Symptom Severity Scale 
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Appendix A 6:  DASH questionnaire 
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